Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3005322	s-ige	u/ml (u/ml)	22871	29120	0.02%
3005322	p-ige	u/ml (u/ml)	3235	4003	0.52%
3005322	s-ige	— (—)	2368	2658	100.00%	Distribution not available
3005322	p-ige	— (—)	238	254	100.00%	Distribution not available
3005322	s-immunoglobuliinie	u/ml (u/ml)	92	96	0.00%
3005322	immunoglobuliinie	u/ml (u/ml)	13	16	0.00%
3005322	s-ige	u/l (u/ml)	9	9	0.00%
3005322	s-immunoglobuliinie	— (—)	7	7	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Acute bronchitis

2216

9202

2.52

320.87

1.6

1.3

252.60

247.15

u/ml

0.08

2050

8488

Medical observation and evaluation for suspected diseases and conditions

3491

8579

2.17

318.33

1.4

1.2

256.60

255.99

u/ml

0.01

3250

7927

Allergic contact dermatitis

1062

3085

3.96

318.07

1.4

1.3

341.94

130.70

u/ml

8.84

994

2839

Other chronic obstructive pulmonary disease, including avohilmo

2285

8102

2.48

313.59

1.5

1.3

334.35

254.53

u/ml

2.27

2126

7434

Acute upper respiratory infections of multiple and unspecified sites

4075

16235

1.97

309.12

1.5

1.2

284.94

226.09

u/ml

1.10

3777

15017

Immunodeficiencies

558

1032

7.35

307.72

1.9

1.2

218.77

210.97

u/ml

0.05

464

949

Allergic asthma (mode), excluding more controls

2581

4190

7.20

307.65

1.8

1.1

556.33

198.56

u/ml

14.76

2485

3811

Asthma, unspecified (mode), excluding more controls

5048

6632

6.96

307.65

1.5

1.1

266.90

203.43

u/ml

1.48

4786

6041

Asthma and allergy, excluding more controls

1616

2310

8.65

307.65

1.8

1.1

713.23

175.99

u/ml

15.77

1559

2094

Asthma, unspecified (mode)

5083

6803

6.87

307.65

1.5

1.1

265.48

209.61

u/ml

1.23

4820

6195

Allergic asthma (mode)

2581

4220

7.14

307.65

1.8

1.1

556.33

202.10

u/ml

14.51

2485

3840

Other soft tissue disorders, not elsewhere classified

4903

16600

1.90

307.65

1.3

188.26

276.27

u/ml

7.80

4550

15340

First line medication for Crohn's disease

7871

16338

2.82

307.65

1.5

1.2

361.53

183.18

u/ml

13.50

7390

15002

Chronic rhinitis, nasopharyngitis and pharyngitis

2641

6792

4.47

307.65

1.5

1.2

212.28

209.47

u/ml

0.04

2467

6248

Vasomotor and allergic rhinitis

3561

9339

4.32

307.65

1.5

1.2

455.99

211.74

u/ml

12.41

3394

8574

COPD/asthma/ILD related infections

5859

15409

1.99

307.65

1.4

1.2

256.67

224.53

u/ml

0.76

5408

14233

Asthma and opportunity respiratory infection

592

525

17.04

307.65

2.3

1.1

280.83

177.05

u/ml

1.84

570

466

Undetermined asthma, excluding more controls

1342

1563

10.79

307.65

1.7

1.1

242.30

202.46

u/ml

0.51

1277

1419

Other respiratory diseases principally affecting the interstitium

1002

2670

4.19

307.65

1.6

1.2

257.08

234.86

u/ml

0.31

936

2424

Asthma-related pneumonia

2809

5812

5.56

307.65

1.7

1.2

316.59

217.35

u/ml

3.57

2674

5235

Symptoms and signs involving the circulatory and respiratory systems

6910

13681

2.70

307.65

1.4

1.2

210.32

285.97

u/ml

4.53

6415

12613

FESS (DNB20)

1137

2750

5.00

307.65

1.9

1.2

280.07

203.69

u/ml

1.31

1089

2554

Sleep disorders (combined)

5273

18626

1.94

307.65

1.4

1.3

240.46

247.44

u/ml

0.11

4911

17232

Acute upper respiratory infections

5808

19003

2.00

307.65

1.5

1.2

278.16

233.37

u/ml

1.06

5382

17551

Suggestive for eosinophilic asthma

1019

1301

10.45

307.65

2.1

1.1

414.10

206.91

u/ml

2.67

998

1168

Sleep apnoea

4708

16747

2.00

307.65

1.4

1.3

226.58

248.44

u/ml

0.63

4402

15486

Bronchitis

5796

20850

1.90

307.65

1.5

1.2

293.77

235.26

u/ml

1.57

5360

19290

Pain in throat and chest

4448

12457

2.29

307.65

1.4

1.2

180.38

285.81

u/ml

8.18

4129

11506

Asthma, including avohilmo

11301

15937

4.67

307.65

1.5

1.2

306.26

202.35

u/ml

8.78

10672

14540

Eosinophilic disease (BM)

246

125

33.95

307.65

2.8

1.1

634.24

87.81

u/ml

3.78

237

111

Asthma (only as main-diagnosis), excluding more controls

8354

7604

7.79

307.65

1.6

1.1

321.60

209.91

u/ml

5.29

7984

6926

6376

16944

2.08

307.65

1.5

1.2

274.81

228.15

u/ml

1.24

5897

15628

Dermatitis and eczema

8049

19284

2.97

307.65

1.4

1.3

478.96

147.68

u/ml

34.36

7498

17807

ILD medications: immunosuppressive drugs

3063

13968

2.21

307.65

1.4

1.2

432.48

174.80

u/ml

7.00

2864

12816

Diseases of the respiratory system

3650

6223

3.10

307.65

1.3

1.1

222.95

193.57

u/ml

0.84

3380

5659

Abnormalities of breathing

6850

13590

3.25

307.65

1.4

1.2

205.61

286.74

u/ml

5.49

6432

12531

Other acute lower respiratory infections

2940

12804

2.32

307.65

1.6

1.3

318.63

253.55

u/ml

1.56

2722

11803

Urticaria and erythema

2870

10107

3.19

307.65

1.5

1.3

361.36

221.84

u/ml

3.69

2714

9319

Dyspnoea

5896

17346

2.81

307.65

1.4

1.3

204.18

254.03

u/ml

2.78

5530

16001

Non-allergic asthma (mode), excluding more controls

1903

2589

8.75

307.65

1.5

1.1

154.24

218.69

u/ml

1.69

1804

2340

Abnormal findings on diagnostic imaging of lung

2489

8422

3.11

307.65

1.5

1.3

241.70

251.85

u/ml

0.18

2320

7731

Cough

3684

7747

5.28

307.65

1.4

1.2

180.92

286.24

u/ml

4.83

3485

7127

Atopic dermatitis, strict definition

2416

9236

2.86

307.65

1.5

1.3

1072.52

142.53

u/ml

28.78

2298

8511

Asthma, hospital admission 2, infections

5671

11947

5.46

307.65

1.7

1.2

346.91

211.91

u/ml

6.19

5399

10836

Asthma (diagnoses ohter than nonallergic)

8831

17843

4.91

307.65

1.6

1.2

347.04

196.93

u/ml

12.42

8431

16272

Ethmoidectomy

1157

2853

4.88

307.65

1.9

1.2

276.53

205.35

u/ml

1.21

1108

2648

ILD differential diagnosis

5101

7858

3.47

307.65

1.4

1.1

233.63

217.51

u/ml

0.37

4747

7157

Atopic dermatitis, strict definition with reimbursement

2559

8243

3.39

307.65

1.6

1.3

1026.16

136.13

u/ml

29.50

2429

7613

Chronic lower respiratory diseases

10939

15708

4.21

307.65

1.5

1.2

314.39

194.74

u/ml

10.43

10348

14306

Asthma, hospital admissions , main diagnosis only

8688

17943

5.06

307.65

1.6

1.2

325.17

209.06

u/ml

7.78

8309

16343

Inflammatory bowel disease treatment related agents

8489

17435

2.99

307.65

1.5

1.2

353.59

194.70

u/ml

12.31

7993

16014

ILD medications: prednisolone, methylprednisolone, prednisone

8356

15997

3.21

307.65

1.5

1.2

365.71

177.78

u/ml

16.34

7870

14676

Excluding asthma or asthma-COPD overlap

5145

7893

3.49

307.65

1.4

1.1

234.62

215.81

u/ml

0.46

4789

7189

4583

9425

5.75

307.65

1.7

1.2

360.24

201.24

u/ml

6.28

4365

8567

Asthma, hospital admissions 3, pneumonia

2813

5833

5.54

307.65

1.7

1.2

316.36

216.99

u/ml

3.59

2678

5254

Asthma (mode)

8642

7858

7.05

307.65

1.6

1.1

324.55

217.51

u/ml

5.21

8235

7157

ILD medications

8351

16542

2.99

307.65

1.5

1.2

363.72

180.26

u/ml

15.35

7851

15171

Obesity related asthma

3037

6147

5.90

307.65

1.5

1.2

247.64

209.72

u/ml

1.29

2908

5573

Non-allergic asthma (mode)

1903

2606

8.69

307.65

1.5

1.1

154.24

223.45

u/ml

1.89

1804

2353

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

887

989

7.68

307.65

1.6

1.2

253.21

314.08

u/ml

0.58

824

913

COPD

1978

4604

3.80

307.65

1.5

1.2

319.98

249.86

u/ml

1.55

1852

4131

Asthma-related pneumonia or sepsis

2813

5833

5.54

307.65

1.7

1.2

316.36

216.99

u/ml

3.59

2678

5254

Atopic dermatitis

4282

13747

2.91

307.65

1.4

1.3

710.54

135.16

u/ml

32.74

4016

12730

Asthma (only as main-diagnosis)

8414

7810

7.71

307.65

1.6

1.1

320.81

215.94

u/ml

4.80

8042

7113

Examination and observation for other reasons

3239

8523

2.43

307.65

1.4

1.2

221.70

256.25

u/ml

0.77

3019

7875

Asthma and allergy

1615

2245

8.90

307.65

1.8

1.1

713.61

173.52

u/ml

15.83

1558

2033

Other pulmonary diagnosis

5211

7893

3.54

307.65

1.4

1.1

235.46

215.81

u/ml

0.49

4854

7189

Undetermined asthma

1342

1592

10.59

307.65

1.7

1.1

242.30

194.51

u/ml

0.76

1277

1449

COPD/asthma related infections

5859

15409

1.99

307.65

1.4

1.2

256.67

224.53

u/ml

0.76

5408

14233

Other special examinations and investigations of persons without complaint or reported diagnosis

3881

8580

2.40

307.65

1.4

1.2

260.07

255.96

u/ml

0.06

3605

7928

Adverse effects, not elsewhere classified

1636

5178

3.64

307.65

1.5

1.3

407.18

219.32

u/ml

4.71

1576

4777

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

3100

10954

2.99

307.65

1.5

1.2

214.34

226.81

u/ml

0.26

2900

10071

Biological medicines for asthma

372

256

62.02

307.65

2.9

1.3

1100.29

228.58

u/ml

5.05

365

231

Dermatitis

4205

13978

3.31

307.65

1.4

1.3

389.18

147.25

u/ml

16.10

3919

12878

Bronchiectasis

818

789

13.85

307.65

1.9

1.1

233.10

174.28

u/ml

0.66

775

708

Asthma

8823

7810

7.08

307.65

1.5

1.1

317.88

215.94

u/ml

4.90

8398

7113

Asthma/COPD (KELA code 203)

8568

15613

4.34

307.65

1.6

1.2

347.53

194.99

u/ml

11.60

8121

14220

Urticaria

2526

8314

3.47

307.65

1.5

1.3

292.49

215.79

u/ml

1.76

2400

7670

Asthma, excluding more controls

8691

7604

7.14

307.65

1.5

1.1

320.17

209.91

u/ml

5.50

8273

6926

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3299

12811

2.54

307.65

1.5

1.3

221.19

247.68

u/ml

0.75

3063

11808

Other and unspecified dermatitis

3580

11605

3.41

307.65

1.4

1.3

364.36

146.42

u/ml

12.65

3343

10690

Pollen allergy

2072

5561

4.47

307.65

1.5

1.3

483.18

205.58

u/ml

8.46

1986

5117

Oral corticosteroids

8421

16372

3.41

307.65

1.5

1.2

362.58

186.44

u/ml

15.17

7936

15045

Pain in joint

3376

9944

2.37

307.65

1.4

1.3

185.62

309.27

u/ml

8.80

3143

9191

Acute sinusitis

3320

13803

2.40

307.65

1.6

1.2

246.51

223.92

u/ml

0.56

3090

12764

Sleep apnoea, including avohilmo

5071

17291

1.99

307.65

1.4

1.3

220.46

252.73

u/ml

1.10

4740

15983

Other diseases of upper respiratory tract

6585

15031

2.41

307.65

1.4

1.2

270.75

226.17

u/ml

1.42

6142

13814

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

4753

15369

2.02

307.65

1.5

1.2

266.09

224.55

u/ml

1.54

4392

14197

Diseases of the skin and subcutaneous tissue

5975

13945

2.25

307.65

1.3

358.79

140.17

u/ml

16.81

5537

12841

Other and unspecified effects of external causes

1918

7560

2.80

307.65

1.5

1.3

383.91

220.03

u/ml

4.84

1840

6985

Allergic rhinitis

3107

8798

4.09

307.65

1.5

1.2

464.41

181.75

u/ml

13.90

2967

8088

Other chronic obstructive pulmonary disease

1842

4413

3.71

307.65

1.5

1.2

324.55

255.95

u/ml

1.38

1724

3959

Gastro-oesophageal reflux disease

3504

15533

2.10

307.65

1.4

1.3

175.74

254.30

u/ml

4.59

3266

14392

Asthma-related infections

5671

11947

5.46

307.65

1.7

1.2

346.91

211.91

u/ml

6.19

5399

10836

Early onset COPD, excluding more controls

1117

2133

5.78

307.65

1.5

1.1

342.23

267.14

u/ml

0.84

1042

1932

COPD differential diagnosis

5104

7862

3.47

307.65

1.4

1.1

233.50

217.42

u/ml

0.37

4750

7161

4753

15369

2.02

307.65

1.5

1.2

266.09

224.55

u/ml

1.54

4392

14197

Chronic sinusitis

3442

9446

4.11

307.65

1.7

1.2

235.29

213.28

u/ml

0.60

3239

8668

Other and unspecified urticaria

1570

5115

3.51

307.65

1.5

1.3

239.86

203.39

u/ml

0.96

1489

4726

Nasal polyp

1333

3182

4.76

307.65

1.8

1.2

402.42

239.33

u/ml

2.34

1289

2932

COPD (mode)

1227

2451

4.23

307.65

1.3

1.1

314.88

282.05

u/ml

0.33

1138

2210

ILD, hospital admissions

868

2238

4.38

306.11

1.6

1.2

254.29

234.27

u/ml

0.24

808

2030

Other interstitial pulmonary diseases

869

2244

4.37

305.53

1.6

1.2

254.25

234.45

u/ml

0.24

809

2034

Certain disorders involving the immune mechanism

1285

4298

3.35

304.24

1.7

1.3

211.90

216.30

u/ml

0.04

1138

3985

Interstitial lung disease

869

2254

4.35

303.66

1.6

1.2

254.25

234.76

u/ml

0.24

809

2043

Interstitial lung disease endpoints

869

2254

4.35

303.66

1.6

1.2

254.25

234.76

u/ml

0.24

809

2043

Episodal and paroxysmal disorders

5955

17848

1.77

302.44

1.4

1.3

235.55

267.28

u/ml

0.71

5509

16504

Any reimbursement code in KELA

3679

9313

2.07

293.51

1.4

1.2

279.18

160.24

u/ml

7.80

3442

8588

General symptoms and signs

5886

17411

1.75

287.65

1.4

1.3

254.51

252.57

u/ml

0.03

5432

16135

Other specific joint derangements/joint disorders

4099

14906

1.93

286.31

1.4

1.3

196.05

268.30

u/ml

4.26

3814

13815

Later onset COPD, excluding more controls

704

1166

5.02

285.92

1.4

1.1

290.65

308.92

u/ml

0.14

662

1030

ILD, hospital admission 2, with pulmonary infections

580

1145

5.81

285.63

1.7

1.2

234.96

204.71

u/ml

0.34

538

1052

Diseases of oesophagus, stomach and duodenum

5401

19205

1.77

285.04

1.4

1.3

197.30

253.79

u/ml

3.80

5020

17814

Childhood asthma (age<16), excluding more controls

971

2147

3.94

284.24

1.6

1.1

811.05

195.88

u/ml

8.94

915

1951

Childhood asthma (age<16)

971

2156

3.92

282.75

1.6

1.1

811.05

195.72

u/ml

8.95

915

1960

Deviated nasal septum

1560

5969

2.78

280.07

1.5

1.2

296.95

264.97

u/ml

0.40

1456

5496

Low back pain

3781

15648

1.94

278.61

1.3

188.27

270.41

u/ml

5.38

3492

14504

Haemorrhage from respiratory passages

1364

4477

2.98

278.23

1.4

1.2

216.98

304.50

u/ml

3.03

1256

4099

Headache

3581

15999

1.96

273.11

1.4

1.3

222.06

246.41

u/ml

0.33

3313

14810

ILD, hospital admissions 1, main diag only

770

1994

4.37

270.18

1.6

1.3

255.78

218.58

u/ml

0.52

719

1815

COPD, hospital admissions

1846

6488

2.54

269.24

1.5

1.3

324.19

257.27

u/ml

1.61

1728

5916

Dorsalgia

5194

16420

1.77

269.18

1.3

205.74

275.80

u/ml

4.32

4794

15198

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2110

4373

2.53

268.32

1.3

1.2

197.17

294.48

u/ml

4.29

1955

4014

COPD, early/later onset

1847

6521

2.52

265.09

1.5

1.3

324.70

256.79

u/ml

1.66

1729

5948

Influenza and pneumonia

5417

21396

1.72

264.63

1.5

1.2

258.91

243.87

u/ml

0.41

5016

19818

Parasetamol

4374

12422

1.86

261.97

1.3

234.35

283.01

u/ml

1.65

4035

11509

Immunodeficiency with predominantly antibody defects

375

558

10.39

260.89

1.8

1.2

74.44

193.14

u/ml

1.98

300

516

Pneumonia, organism unspecified

4473

18628

1.80

259.53

1.5

1.3

291.64

247.52

u/ml

1.20

4128

17239

Disorders of conjunctiva

4364

21120

1.80

257.93

1.4

1.3

394.21

211.52

u/ml

6.70

4107

19475

Pneumonias (Asthma/COPD co-morbidities)

5051

20868

1.74

256.18

1.5

1.3

267.95

243.89

u/ml

0.69

4670

19342

All pneumoniae

5069

20974

1.73

251.83

1.5

1.3

267.75

243.64

u/ml

0.70

4686

19438

Conjunctivitis

4082

20373

1.82

251.39

1.4

1.3

407.42

208.73

u/ml

7.03

3848

18782

Pain in limb

3862

15684

1.85

243.93

1.4

1.3

193.65

270.38

u/ml

5.58

3594

14510

Other dorsopathies, not elsewhere classified

5216

16557

1.72

240.50

1.3

200.63

277.74

u/ml

5.42

4819

15322

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

4861

20539

1.72

239.58

1.5

1.3

270.78

243.56

u/ml

0.79

4486

19041

Voice disturbances

1503

6158

2.65

238.46

1.5

1.3

155.50

225.32

u/ml

2.47

1406

5657

Lower back pain or/and sciatica

5066

21421

1.70

236.28

1.3

197.67

254.61

u/ml

3.71

4675

19854

Dermatographic urticaria

630

1593

4.85

234.95

1.6

1.3

238.62

190.27

u/ml

0.84

599

1471

Pruritus

730

2023

4.10

233.48

1.4

1.2

320.02

122.69

u/ml

4.25

689

1857

Fever of other and unknown origin

2645

12694

2.02

225.58

1.4

1.3

250.98

251.38

u/ml

0.01

2453

11743

Non-allergic asthma

628

1607

4.50

225.36

1.3

108.76

138.30

u/ml

1.52

588

1475

Abnormalities of heart beat

1554

6515

2.49

224.60

1.3

1.2

161.05

274.18

u/ml

3.67

1422

5970

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

3040

16437

1.91

219.64

1.5

1.3

456.94

198.16

u/ml

7.26

2890

15165

Early onset COPD

1117

4107

2.94

219.20

1.5

1.3

342.23

250.48

u/ml

1.44

1042

3778

Chronic diseases of tonsils and adenoids

3772

13624

1.81

218.97

1.3

1.2

279.11

216.12

u/ml

0.97

3526

12524

Eosinophilia

247

276

15.05

218.59

2.8

1.2

631.59

254.50

u/ml

1.64

238

256

Allergic conjunctivitis

3163

17371

1.88

218.07

1.5

1.3

457.20

197.97

u/ml

7.67

3000

16026

Migraine

2842

13010

1.95

214.72

1.4

1.3

201.06

224.47

u/ml

0.27

2657

12029

Neurological diseases

4675

14179

1.71

212.20

1.4

1.3

232.72

269.85

u/ml

0.75

4336

13107

COPD, hospital admissions 1, only main diagnosis

1360

4687

2.61

209.95

1.5

1.3

303.31

251.46

u/ml

1.23

1274

4279

Soft tissue disorders

5249

17020

1.65

208.80

1.3

203.56

280.81

u/ml

5.52

4883

15727

General examination and investigation of persons without complaint and reported diagnosis

3020

8576

1.94

207.50

1.4

1.2

227.34

256.06

u/ml

0.69

2802

7924

Codeine

4824

16294

1.68

207.14

1.4

1.3

228.26

241.09

u/ml

0.31

4456

15109

Symptoms and signs involving speech and voice

1662

7556

2.35

206.27

1.5

1.3

172.60

230.31

u/ml

1.83

1556

6940

Desensitization to allergens

579

1522

4.73

206.14

1.6

1.3

597.44

208.48

u/ml

3.05

562

1412

COPD, hospital admission 2, with asthma infections

1241

4187

2.67

201.00

1.5

1.3

323.48

254.82

u/ml

1.10

1160

3825

ILD, hospital admissions 3, with pneumonia sepsis

453

980

5.23

200.21

1.7

1.2

209.83

216.70

u/ml

0.06

419

900

Persons encountering health services for examination and investigation

3137

8580

1.89

197.98

1.3

1.2

221.12

255.96

u/ml

0.95

2918

7928

Dorsopathies

5189

16729

1.63

195.76

1.3

216.09

280.54

u/ml

3.54

4811

15486

Other intervertebral disc disorders

3866

14014

1.74

195.48

1.4

1.3

187.18

267.78

u/ml

5.04

3586

13005

Opioids

5053

16689

1.64

195.41

1.4

1.3

238.41

247.50

u/ml

0.20

4676

15467

Emphysema

339

581

6.50

192.80

1.4

1.1

218.93

209.49

u/ml

0.09

313

521

Chronic laryngitis and laryngotracheitis

737

2316

3.49

191.60

1.5

1.2

216.72

186.92

u/ml

0.52

687

2129

Codeine or tramadol medication

5508

19786

1.59

189.34

1.4

1.3

226.30

243.43

u/ml

0.52

5083

18346

Other joint disorders

4622

15301

1.66

188.58

1.4

1.3

213.29

267.98

u/ml

2.58

4295

14182

Asthma mixed form (mode), excluding more controls

337

601

6.33

184.59

1.5

1.1

325.76

188.01

u/ml

0.98

324

549

Pain (limb, back, neck, head abdominally)

3582

10429

1.77

184.00

1.3

212.92

312.87

u/ml

5.27

3327

9650

COPD related to multimorbidity

1401

5144

2.40

182.62

1.4

1.3

337.22

253.97

u/ml

1.66

1310

4692

Neurological diseases, wide definition

1925

4578

2.21

181.36

1.3

1.2

234.75

313.49

u/ml

1.43

1781

4237

Other headache syndromes

2162

11333

2.00

181.34

1.4

1.3

195.25

222.93

u/ml

0.42

2010

10468

Asthma mixed form (mode)

337

613

6.21

180.82

1.5

1.1

325.76

193.94

u/ml

0.92

324

562

Autoimmune diseases related-to ILD

3972

21716

1.66

178.47

1.4

1.3

221.64

252.52

u/ml

0.98

3692

20109

Systemic connective tissue disorders

1683

8183

2.18

175.31

1.4

1.3

186.53

219.33

u/ml

0.83

1548

7507

Tramadol

3625

14047

1.71

173.45

1.4

1.3

226.40

235.13

u/ml

0.17

3344

13038

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

4476

20516

1.61

172.45

1.5

1.3

290.98

232.67

u/ml

1.63

4103

19072

Depression or dysthymia

3367

11189

1.74

165.23

1.3

253.50

254.02

u/ml

0.01

3092

10409

Irritable bowel syndrome

1487

7069

2.24

165.03

1.4

1.3

142.58

220.36

u/ml

3.70

1385

6515

Other diseases of intestines

5207

20043

1.55

164.65

1.3

187.37

268.50

u/ml

7.37

4829

18574

Sciatica+with lumbago

2297

12025

1.89

162.07

1.3

217.70

255.25

u/ml

0.84

2125

11145

Abdominal and pelvic pain

4826

15732

1.58

161.94

1.3

210.26

292.92

u/ml

5.07

4476

14537

Symptoms and signs involving the digestive system and abdomen

4831

15738

1.58

160.12

1.3

209.55

292.87

u/ml

5.18

4483

14543

Other diseases of pleura

1630

7088

2.12

159.87

1.5

1.3

225.18

263.75

u/ml

1.02

1514

6505

Diseases of the eye and adnexa

4429

14178

1.61

158.81

1.4

1.3

340.38

222.11

u/ml

3.26

4115

13119

Anxiety disorders, excluding more controls

4147

17567

1.61

158.67

1.4

1.3

253.60

230.98

u/ml

0.33

3811

16331

Recurrent or chronic depression

2207

8636

1.93

157.59

1.3

221.19

241.56

u/ml

0.37

2043

8059

Neurotic, stress-related and somatoform disorders

4430

20561

1.58

156.17

1.4

1.3

257.57

242.45

u/ml

0.21

4075

19071

Anxiety disorders

4455

20640

1.58

156.03

1.4

1.3

256.46

242.50

u/ml

0.19

4097

19143

Oedema, not elsewhere classified

1332

6160

2.26

154.63

1.4

1.3

276.34

235.65

u/ml

0.52

1247

5661

Polypectomy (DHB20)

445

1173

4.36

153.64

1.9

1.2

378.75

242.82

u/ml

1.50

435

1086

Other disorders of lacrimal gland

1619

8153

2.10

153.49

1.4

1.3

224.68

207.10

u/ml

0.30

1489

7489

Vocal cord dysfunction

787

2676

2.95

153.27

1.5

1.2

131.63

203.95

u/ml

3.79

748

2484

Disorders of lacrimal system

1910

10196

1.97

151.84

1.4

1.3

219.28

215.25

u/ml

0.07

1760

9374

Diseases of the musculoskeletal system and connective tissue

2950

8607

1.77

151.81

1.3

217.16

302.44

u/ml

3.28

2750

7975

Other diseases of the respiratory system

838

3202

2.79

151.55

1.5

1.3

176.87

239.93

u/ml

2.12

779

2937

Other respiratory disorders and diseases

838

3202

2.79

151.55

1.5

1.3

176.87

239.93

u/ml

2.12

779

2937

Provisional assignment of new diseases of uncertain etiology

2231

12530

1.86

150.68

1.4

1.3

195.21

246.65

u/ml

1.96

2052

11609

Codes for special purposes

2232

12543

1.86

150.45

1.4

1.3

195.12

246.49

u/ml

1.95

2053

11621

Gastrointestinal diseases

3303

9969

1.71

149.91

1.3

1.2

211.33

272.52

u/ml

2.16

3069

9206

Spondylopathies

3310

12249

1.69

149.82

1.3

207.62

275.46

u/ml

2.78

3062

11347

Spondylosis

2127

10012

1.89

149.17

1.4

1.3

199.92

282.22

u/ml

3.20

1974

9274

Shoulder lesions

3306

12371

1.68

148.45

1.3

167.27

270.20

u/ml

8.13

3081

11438

Infective dermatitis

611

2007

3.34

147.93

1.4

1.3

814.07

150.61

u/ml

7.59

574

1843

Other disorders of white blood cells

401

1014

4.67

147.88

2.3

1.3

526.81

222.16

u/ml

2.38

373

941

Lumbar disc prolapse

2793

13188

1.74

147.16

1.4

1.3

177.45

265.02

u/ml

5.72

2595

12236

Arthropathies

4601

15398

1.56

145.82

1.3

220.28

270.93

u/ml

2.19

4261

14274

Other antidepressants

4804

16653

1.54

145.77

1.3

291.01

248.56

u/ml

0.75

4411

15453

Other systemic involvement of connective tissue (FG)

1232

5673

2.28

145.00

1.4

1.3

182.86

199.83

u/ml

0.36

1115

5210

Any gastric operation

4280

13936

1.58

143.48

1.4

1.2

266.35

242.31

u/ml

0.34

3947

12918

GASTRO-related operations

4280

13936

1.58

143.48

1.4

1.2

266.35

242.31

u/ml

0.34

3947

12918

Disorders of eyelid, lacrimal system and orbit

3685

18525

1.61

142.98

1.4

1.3

296.24

234.27

u/ml

1.04

3393

17164

Symptoms and signs involving the skin and subcutaneous tissue

3091

19115

1.66

142.29

1.4

1.3

265.03

225.17

u/ml

0.97

2868

17706

Bacterial pneumonia (organism specified)

1731

8287

1.98

140.29

1.7

1.2

253.09

242.58

u/ml

0.17

1600

7601

Other and unspecified immunodeficiencies with predominantly antibody defects

185

254

11.82

139.08

2.0

1.2

50.95

222.48

u/ml

1.18

142

233

Certain infectious and parasitic diseases

4921

16611

1.52

138.28

1.4

1.2

319.85

208.07

u/ml

3.52

4542

15366

Nerve, nerve root and plexus disorders

4647

19649

1.52

137.90

1.3

203.63

243.83

u/ml

1.90

4331

18201

Lichen simplex chronicus and prurigo

394

1029

4.37

137.48

1.5

1.2

846.68

150.88

u/ml

3.50

373

938

Follow-up examination after treatment for conditions other than malignant neoplasms

1950

6943

1.90

133.44

1.4

1.2

174.25

240.14

u/ml

2.92

1824

6417

Nummular dermatitis

435

1247

3.88

131.57

1.4

1.3

509.68

154.79

u/ml

3.17

409

1140

Diagnoses used for exclusion with ILD

1087

4982

2.30

131.37

1.5

1.3

209.06

232.73

u/ml

0.31

993

4600

COPD, hospital admissions 3, with asthma pneumonia sepsis

914

3257

2.50

130.65

1.6

1.3

310.99

263.29

u/ml

0.74

850

2970

Bacterial pneumoniae

1627

7599

1.97

130.00

1.7

1.2

244.34

240.27

u/ml

0.06

1504

6996

Persons encountering health services for other counselling and medical advice, not elsewhere classified

5091

20076

1.48

129.23

1.4

1.3

266.51

247.83

u/ml

0.42

4769

18576

Persons encountering health services in other circumstances, wide

5534

20136

1.46

127.87

1.4

1.3

264.99

247.63

u/ml

0.44

5124

18628

Simple and mucopurulent chronic bronchitis

232

414

6.30

127.04

1.7

1.2

177.31

196.38

u/ml

0.11

220

371

Dysphagia

995

4480

2.34

125.38

1.4

1.3

187.47

246.16

u/ml

1.59

917

4103

Other systemic involvement of connective tissue

1255

6204

2.14

125.16

1.4

1.3

182.78

197.53

u/ml

0.31

1135

5670

Temporomandibular joint disorders

864

3681

2.51

124.90

1.4

1.2

141.53

229.18

u/ml

3.04

805

3405

Myalgia

1148

5510

2.21

124.19

1.4

1.3

194.74

228.56

u/ml

0.58

1071

5063

Bacterial pneumonia, not elsewhere classified

1530

7109

1.98

124.07

1.7

1.2

249.18

236.93

u/ml

0.19

1417

6541

Prurigo nodularis

211

364

7.33

123.20

1.6

1.2

1003.45

150.26

u/ml

2.98

205

328

Personal history of allergy to drugs, medicaments and biological substances

164

231

11.29

120.35

2.0

1.2

227.70

283.61

u/ml

0.22

157

217

Enlarged lymph nodes

795

3320

2.56

120.27

1.6

1.3

661.54

242.05

u/ml

1.97

731

3078

Respiratory insufficiency

264

557

5.04

117.82

1.3

1.1

189.05

236.43

u/ml

0.52

240

494

Autoimmune diseases excluding thyroid diseases

4767

18425

1.47

115.94

1.4

1.3

278.03

253.60

u/ml

0.58

4430

17079

Rotator cuff syndrome

2417

10904

1.70

115.54

1.3

182.28

280.66

u/ml

4.56

2251

10081

Kela reimbursement Agammaglobulinemia (D80-84)

140

178

13.87

113.28

2.1

1.2

80.79

258.20

u/ml

0.71

164

Allergic urticaria

543

1958

3.10

113.12

1.6

1.3

398.34

208.40

u/ml

2.11

513

1802

Cardiovascular diseases

3495

12539

1.56

112.79

1.4

1.3

215.34

261.62

u/ml

1.31

3274

11628

Mood disorders

4693

21656

1.46

112.76

1.3

252.39

248.89

u/ml

0.05

4282

20121

Infections, IBD-co-morbidities

718

2067

2.66

112.29

1.5

1.2

234.77

288.60

u/ml

0.75

646

1917

Mood [affective] disorders

4683

21651

1.46

112.25

1.3

252.74

248.64

u/ml

0.05

4273

20116

Used for control exclusion in common control thyroid runs

4917

17502

1.45

112.20

1.4

1.3

274.87

258.86

u/ml

0.23

4544

16226

Other diseases of hard tissues of teeth

2910

13926

1.60

111.51

1.4

1.3

213.16

249.47

u/ml

0.98

2694

12917

Autoimmune diseases excluding thyroid diseases, strict definition

4623

17974

1.46

111.34

1.4

1.3

283.22

256.97

u/ml

0.61

4296

16659

Diseases of the ear and mastoid process

5507

20022

1.42

110.54

1.4

1.3

232.62

249.87

u/ml

0.33

5084

18571

Autoimmune diseases

5131

18602

1.44

110.37

1.4

1.3

276.75

252.96

u/ml

0.40

4728

17239

Depression

4416

21251

1.47

110.20

1.3

252.86

245.94

u/ml

0.09

4041

19750

D07AA Corticosteroids, weak (group I)

929

4323

2.31

110.06

1.6

1.3

1549.85

191.80

u/ml

14.41

875

4007

Persons encountering health services for specific procedures and health care

4881

21451

1.44

109.71

1.4

1.3

290.59

238.97

u/ml

1.10

4526

19865

Exposure to unspecified factor

4303

23355

1.46

108.88

1.4

1.3

266.93

247.60

u/ml

0.50

3999

21611

Migraine with aura

1293

6805

2.01

108.28

1.4

1.3

164.52

206.76

u/ml

1.24

1219

6270

Viral Sepsis

814

3595

2.40

107.95

1.4

1.3

243.04

237.39

u/ml

0.05

746

3314

Temporomandibular joint disorders, including avohilmo

2180

13355

1.70

107.31

1.3

160.39

218.38

u/ml

2.85

2027

12316

Implicit viral Sepsis

810

3583

2.39

107.02

1.4

1.3

208.11

237.82

u/ml

0.45

742

3302

Childhood allergy (age < 16)

1015

4025

2.23

106.62

1.5

1.3

932.25

193.83

u/ml

7.30

957

3667

Pain, not elsewhere classified

1231

6389

2.02

106.47

1.4

1.2

173.28

232.11

u/ml

1.85

1138

5904

Functional dyspepsia

1194

6146

2.04

106.09

1.4

1.3

213.78

234.17

u/ml

0.24

1107

5650

Depression medications

1858

5290

1.83

106.09

1.3

260.42

262.94

u/ml

0.02

1720

4939

Other/unspecified dorsalgia

1589

8899

1.84

105.61

1.4

1.3

179.37

261.59

u/ml

3.48

1485

8205

All influenza

1053

5184

2.13

105.60

1.6

1.2

261.46

239.71

u/ml

0.27

981

4806

Dermatitis due to ingested food

347

972

4.13

105.21

1.8

1.3

1344.40

189.38

u/ml

6.27

337

899

Mood disorders, excluding more controls

4282

18186

1.47

105.09

1.3

253.14

233.54

u/ml

0.29

3903

16904

Mycoses

1156

5931

2.05

103.92

1.8

1.3

432.84

219.23

u/ml

3.19

1074

5468

Other symptoms and signs involving the circulatory and respiratory systems

330

919

3.95

103.78

1.4

1.2

167.77

232.16

u/ml

0.87

305

853

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

521

1923

3.00

103.42

1.6

1.3

285.92

205.77

u/ml

0.88

493

1776

Finngen Rheumatological endpoints

4475

17960

1.45

103.39

1.3

215.91

251.94

u/ml

1.46

4135

16703

Disorders of synovium and tendon

2278

12750

1.66

103.15

1.4

1.3

194.38

261.86

u/ml

2.93

2129

11780

Care involving use of rehabilitation procedures

2724

16790

1.58

103.03

1.4

1.3

262.52

237.13

u/ml

0.26

2539

15545

Other heart diseases, wide

4294

18691

1.46

102.99

1.4

1.3

212.35

253.77

u/ml

1.61

4001

17370

Drug-induced adrenocortical insufficiency

187

350

7.31

102.41

2.6

1.2

525.21

202.32

u/ml

0.84

179

323

Complications of surgical and medical care, not elsewhere classified

4128

20737

1.46

102.26

1.4

1.3

273.17

234.44

u/ml

0.65

3846

19206

Other immunodeficiencies

151

232

9.88

102.04

2.2

1.2

321.59

225.05

u/ml

0.29

145

212

Oxicams

957

2484

2.27

101.77

1.3

171.37

323.86

u/ml

3.96

882

2295

Unspecified chronic bronchitis

185

330

6.24

101.15

1.7

1.1

168.21

202.62

u/ml

0.17

173

294

Other arthrosis

2024

8680

1.72

101.09

1.3

187.68

260.14

u/ml

3.96

1890

8066

Hypothyroidism, strict autoimmune

3282

14582

1.53

100.07

1.3

203.85

228.26

u/ml

0.33

3015

13495

L04AX Other immunosuppressants

2429

15517

1.62

99.96

1.4

1.3

399.06

222.33

u/ml

3.16

2269

14358

Nonhereditary hypogammaglobulinemia

140

203

10.41

99.45

1.9

1.2

65.38

265.44

u/ml

1.05

103

187

Triptan medication for migraine, single purchase ok

3784

17747

1.48

99.40

1.3

197.65

245.27

u/ml

0.93

3520

16406

Migraine, single triptan purchase ok & required. ICD-code if available is included

3784

17747

1.48

99.40

1.3

197.65

245.27

u/ml

0.93

3520

16406

Coxibs

1201

3206

2.06

98.79

1.3

199.22

356.55

u/ml

4.66

1101

2958

Disorders of thyroid, IBD co-morbidities

855

2831

2.30

98.60

1.4

1.2

157.87

257.88

u/ml

3.32

809

2640

Dentofacial anomalies [including malocclusion]

1424

7865

1.88

98.43

1.4

1.3

153.88

233.87

u/ml

4.40

1343

7297

Cardiovascular diseases (excluding rheumatic etc)

3491

13702

1.51

98.13

1.4

1.3

208.52

248.91

u/ml

1.22

3269

12753

Second line medication for Crohn's disease

2484

16017

1.60

98.09

1.4

1.3

392.34

223.85

u/ml

3.02

2319

14825

Disorders of skin appendages

2213

13914

1.65

97.62

1.3

256.47

251.70

u/ml

0.07

2067

12845

Anaemias

1280

4496

1.98

97.40

1.4

1.3

298.13

242.31

u/ml

0.77

1183

4216

163

272

7.20

97.28

2.1

1.2

333.31

152.34

u/ml

2.66

155

245

Complications of medical and surgical care

2953

18752

1.54

97.08

1.4

1.3

287.29

228.72

u/ml

0.81

2754

17342

All anxiety disorders

3027

16367

1.53

95.81

1.4

1.3

275.34

238.85

u/ml

0.42

2776

15226

Malaise and fatigue

1857

9273

1.72

95.44

1.4

1.3

245.49

243.34

u/ml

0.02

1719

8536

Cervicobrachial syndrome

1015

5127

2.08

95.30

1.3

223.29

242.89

u/ml

0.16

925

4729

Unspecified acute lower respiratory infection

701

3073

2.43

95.17

1.7

1.3

448.19

245.25

u/ml

1.86

654

2862

Idiopathic urticaria

208

453

5.91

95.05

1.6

1.3

219.18

226.60

u/ml

0.04

203

411

Idiopathic pulmonary fibrosis

317

912

3.79

94.80

1.6

1.2

258.29

223.82

u/ml

0.26

291

830

Diaphragmatic hernia

1341

7421

1.88

94.60

1.3

213.04

225.77

u/ml

0.16

1242

6810

Other nutritional deficiencies

2909

19125

1.53

94.01

1.3

271.15

228.00

u/ml

0.82

2713

17730

Antihypertensive medication - note that there are other indications

3359

12477

1.51

93.76

1.3

217.40

255.73

u/ml

0.94

3128

11563

Factors influencing health status and contact with health services

1314

3459

1.96

93.20

1.3

1.2

242.87

314.06

u/ml

0.99

1218

3194

Selective serotonin reuptake inhibitors

4460

16790

1.43

92.60

1.3

300.44

249.57

u/ml

0.88

4096

15584

Disorders of the thyroid gland

4131

19231

1.43

91.86

1.3

185.58

245.43

u/ml

1.57

3809

17827

Continuous positive airway pressure

802

3202

2.26

91.85

1.4

1.3

227.86

277.23

u/ml

0.87

751

2986

Bronchitis, not specified as acute or chronic

362

1155

3.36

91.20

1.6

1.1

280.90

213.71

u/ml

0.72

340

1053

Anxiety (asthma-related co-morbidities)

2969

15827

1.52

90.77

1.4

1.3

276.88

234.17

u/ml

0.50

2725

14773

Hypothyroidism (congenital or acquired)

1524

4946

1.84

90.63

1.3

222.14

241.26

u/ml

0.11

1411

4630

Cervical disc disorders

1401

7963

1.82

90.13

1.4

1.3

170.46

274.43

u/ml

4.79

1303

7352

Other enthesopathies

1303

7272

1.87

89.75

1.3

207.13

258.69

u/ml

1.09

1215

6729

Hypothyroidism, levothyroxine purchases

1512

4916

1.84

89.74

1.3

224.74

242.18

u/ml

0.10

1398

4601

Hypothyroidism and >3 levothyroxin purchases

1512

4916

1.84

89.74

1.3

224.74

242.18

u/ml

0.10

1398

4601

Covid-19 confirmed case

1219

6683

1.91

89.32

1.4

1.3

211.46

246.32

u/ml

0.61

1130

6159

Non-invasive ventilation

942

4434

2.09

88.99

1.6

1.3

177.63

228.94

u/ml

1.66

850

4116

Fibromyalgia

518

2064

2.75

88.19

1.4

1.3

108.59

188.65

u/ml

3.06

482

1900

Adrenocortical insufficiency

262

713

4.35

87.81

2.3

1.2

500.92

216.09

u/ml

1.07

252

652

Other and unspecified drugs and medicaments

463

1754

2.91

87.43

1.6

1.3

297.48

213.14

u/ml

0.82

440

1617

Other complications of surgical and medical care, not elsewhere classified

522

2094

2.72

87.31

1.6

1.3

317.35

203.20

u/ml

0.98

491

1936

Other disorders of skin and subcutaneous tissue

2595

15808

1.54

87.26

1.4

1.3

263.07

232.30

u/ml

0.69

2390

14615

Selective deficiency of immunoglobulin G [IgG] subclasses

110

143

12.99

87.01

1.8

1.2

81.86

303.69

u/ml

0.77

101

135

Other functional intestinal disorders

1758

10205

1.69

86.71

1.4

1.3

159.95

252.69

u/ml

5.44

1638

9393

Hypothyroidism, other/unspecified

3881

18245

1.44

86.65

1.3

191.91

235.71

u/ml

0.91

3581

16904

Somatoform disorder

830

4058

2.18

86.21

1.5

1.3

170.94

195.50

u/ml

0.44

763

3751

Other heart diseases

2376

10177

1.59

85.63

1.4

1.3

227.13

245.25

u/ml

0.31

2221

9481

Later onset COPD

734

2620

2.28

85.24

1.4

1.3

296.99

276.67

u/ml

0.25

691

2355

Symptoms and signs involving the nervous and musculoskeletal systems

2320

15187

1.57

85.21

1.4

1.3

198.26

241.59

u/ml

1.33

2148

14043

Other anxiety disorders

2244

12982

1.58

83.07

1.4

1.3

255.10

240.15

u/ml

0.20

2057

12038

Polyarthropathies

2756

12374

1.52

82.41

1.3

239.88

260.25

u/ml

0.40

2533

11503

Aspergillosis

101

124

12.37

82.29

4.9

1.2

1389.88

212.84

u/ml

2.42

113

Hypothyreosis and Thyroxine purchase for inclusion criteria

3974

18947

1.41

81.65

1.3

189.70

232.16

u/ml

0.90

3669

17548

Spinal stenosis

1614

7596

1.71

81.16

1.3

216.02

269.88

u/ml

1.69

1471

7014

Implicit Sepsis

2717

14331

1.51

80.54

1.4

1.3

263.61

244.29

u/ml

0.28

2504

13254

Migraine without aura

1088

5967

1.92

80.52

1.4

1.3

265.93

192.75

u/ml

0.36

1023

5505

Implicit bacterial Sepsis

1233

6373

1.83

80.04

1.4

1.3

320.11

251.56

u/ml

0.79

1127

5851

Other noninfective gastroenteritis and colitis

1076

5873

1.92

79.90

1.5

1.3

311.06

224.67

u/ml

1.44

997

5422

Other diseases of blood and blood-forming organs, wide

914

4740

2.03

79.81

1.8

1.3

339.39

214.17

u/ml

1.84

829

4381

ILD medications: azathioprine

661

3040

2.30

79.69

1.3

1.2

188.49

178.66

u/ml

0.13

613

2783

Intestinal infectious diseases

3994

22661

1.40

79.60

1.4

1.3

253.11

244.24

u/ml

0.11

3699

20964

Hypertensive diseases (excluding secondary)

2582

10023

1.54

79.17

1.3

229.27

237.59

u/ml

0.12

2417

9355

Other disorders of adrenal gland

301

958

3.61

78.87

2.2

1.2

460.52

219.07

u/ml

1.03

289

881

Cardiac arrhythmias

2973

13581

1.48

78.70

1.3

195.91

234.40

u/ml

1.14

2772

12670

Complications of procedures, not elsewhere classified

3240

19804

1.45

78.43

1.4

1.3

273.99

231.61

u/ml

0.57

3011

18336

COPD-related respiratory insufficiency

396

1452

2.89

77.71

1.6

1.3

298.44

248.18

u/ml

0.60

374

1322

Cervicalgia

840

4266

2.06

77.48

1.4

1.3

185.69

225.99

u/ml

0.92

776

3921

Obesity and other hyperalimentation

2709

18514

1.49

76.86

1.3

265.15

228.31

u/ml

0.64

2529

17159

Rheumatism, unspecified

634

2917

2.31

76.71

1.4

1.3

124.88

186.11

u/ml

2.40

587

2666

Sarcoidosis

619

2828

2.34

76.58

1.4

1.3

144.21

216.17

u/ml

0.98

571

2618

Obesity

2691

18449

1.48

75.39

1.3

265.61

228.69

u/ml

0.64

2515

17098

Concussion

2083

11777

1.57

75.39

1.3

248.23

267.84

u/ml

0.26

1929

10892

Noninfective enteritis and colitis

1976

12841

1.58

75.04

1.4

1.3

256.41

253.73

u/ml

0.03

1833

11882

Soft tissue disorders related to use, overuse and pressure

1012

5519

1.91

75.04

1.3

268.35

251.42

u/ml

0.17

943

5071

Hypertension, essential

3331

13452

1.44

75.03

1.3

254.66

228.17

u/ml

0.56

3112

12499

Exfoliative dermatitis

128

9.91

74.07

2.1

1.2

3490.86

187.38

u/ml

4.95

112

Dizziness and giddiness

2904

16489

1.46

74.07

1.3

184.64

245.32

u/ml

3.28

2667

15251

Bacterial Sepsis

1428

7626

1.71

73.69

1.4

1.3

309.68

250.33

u/ml

0.78

1302

7023

Azathioprine

661

3144

2.22

73.25

1.3

1.2

188.49

179.50

u/ml

0.12

613

2877

ILD-related respiratory insufficiency

175

400

5.03

73.09

1.6

1.2

262.83

206.63

u/ml

0.44

159

361

Dermatitis due to substances taken internally

300

988

3.35

73.01

1.6

1.2

544.42

135.30

u/ml

3.96

280

901

Pain in thoracic spine

672

3222

2.20

73.01

1.4

1.3

139.16

214.23

u/ml

2.53

622

2973

Pain and other conditions associated with female genital organs and menstrual cycle

1126

6157

1.85

72.88

1.3

165.96

205.67

u/ml

1.11

1046

5696

Acetic acid derivatives and related substances

1113

3141

1.90

72.86

1.3

176.87

356.44

u/ml

6.10

1021

2901

Migraine with aura and triptan purchases

865

4567

2.02

72.82

1.4

1.3

149.65

194.49

u/ml

1.33

819

4235

Persons encountering health services in other circumstances

1639

10293

1.64

72.48

1.4

1.3

251.22

245.33

u/ml

0.07

1498

9505

Disturbances of skin sensation

1245

7328

1.77

71.90

1.4

1.3

241.88

217.82

u/ml

0.24

1165

6768

Viral pneumonia

541

2396

2.40

71.72

1.6

1.2

281.94

197.44

u/ml

0.85

498

2212

Congenital malformations of trachea and bronchus

107

165

9.25

71.37

2.1

1.3

104.88

269.30

u/ml

0.57

147

Other symptoms and signs involving the nervous and musculoskeletal systems

1740

11133

1.61

71.36

1.4

1.3

176.09

234.15

u/ml

2.85

1615

10290

Internal derangement of knee

1497

9201

1.67

71.34

1.3

249.76

275.84

u/ml

0.34

1397

8532

Diverticular disease of intestine

2488

11238

1.50

70.91

1.3

215.20

254.28

u/ml

0.85

2300

10406

Arthrosis

2823

10742

1.47

70.83

1.3

217.19

258.50

u/ml

1.21

2609

9990

Symptoms and signs involving cognition, perception, emotional state and behaviour

3930

20363

1.38

70.56

1.4

1.3

208.57

249.11

u/ml

1.38

3635

18868

Diseases of oral cavity, salivary glands and jaws

3845

14403

1.39

70.23

1.3

242.82

248.43

u/ml

0.07

3531

13351

Other general symptoms and signs

323

1129

3.16

69.83

1.6

1.3

139.75

249.10

u/ml

2.67

313

1053

Other arrhythmias

2612

13855

1.48

69.74

1.3

159.35

252.06

u/ml

6.51

2404

12866

Endocrine, nutritional and metabolic diseases

3971

14857

1.39

69.64

1.4

1.3

258.84

251.99

u/ml

0.08

3656

13792

Diarrhoea and gastroenteritis of presumed infectious origin

2948

19107

1.43

68.63

1.4

1.3

247.50

251.70

u/ml

0.04

2739

17667

Dental caries

1056

5937

1.83

68.63

1.5

1.3

284.36

271.29

u/ml

0.13

976

5525

Other disorders of urethra and urinary system

2895

15354

1.44

68.55

1.4

1.3

209.50

221.32

u/ml

0.22

2666

14161

Pulmonary eosinophilia, not elsewhere classified

113

190

7.73

68.26

2.6

1.2

400.14

193.07

u/ml

1.39

106

171

Viral infections characterized by skin and mucous membrane lesions

1695

10903

1.60

67.70

1.5

1.3

544.41

225.80

u/ml

3.84

1568

10078

Obesity due to excess calories

1998

13338

1.54

67.68

1.3

277.74

227.49

u/ml

0.73

1873

12330

Dyshidrosis [pompholyx]

144

306

5.90

67.36

1.3

1.2

359.01

158.95

u/ml

2.24

135

280

Triptan medication for migraine, min. 3 purchases

2778

15535

1.45

66.88

1.3

176.65

210.86

u/ml

0.43

2606

14404

Other and unspecified rosacea

432

1809

2.60

66.14

1.3

196.02

185.77

u/ml

0.11

413

1672

Disorders of other endocrine glands

1802

11621

1.57

66.14

1.5

1.3

232.86

232.92

u/ml

0.00

1679

10712

Other bacterial diseases

3629

18521

1.38

65.60

1.5

1.3

401.08

225.76

u/ml

4.94

3336

17177

Heart failure, not strict

2575

12362

1.47

65.48

1.3

277.34

239.04

u/ml

0.89

2386

11421

Constipation

3352

17529

1.40

65.38

1.3

171.30

254.73

u/ml

5.80

3081

16237

Other diseases of urinary system

4362

18551

1.35

65.03

1.3

217.45

241.97

u/ml

0.69

4025

17181

Seborrhoeic dermatitis

393

1579

2.66

64.82

1.3

174.39

156.71

u/ml

0.20

357

1451

Meniscus derangement

2084

9554

1.53

64.46

1.3

203.73

272.98

u/ml

2.80

1925

8875

Diseases of pulp and periapical tissues

1365

8447

1.67

64.22

1.4

1.3

271.24

242.85

u/ml

0.51

1274

7855

Cystitis

3660

16567

1.38

63.78

1.3

222.40

227.84

u/ml

0.10

3387

15293

Visual disturbances

1820

12068

1.55

63.39

1.4

1.3

250.10

236.69

u/ml

0.16

1673

11117

L04AA Selective immunosuppressants

951

5385

1.85

63.21

1.5

1.3

486.23

219.68

u/ml

1.64

884

4993

Papulosquamous disorders

1508

9612

1.62

62.90

1.4

1.3

355.67

223.72

u/ml

3.37

1411

8859

Dental operations

2449

8635

1.48

62.81

1.3

212.13

267.51

u/ml

1.87

2251

8005

Hypothyroidism, strict autoimmune, 3 medication purchases required

3557

17983

1.38

62.77

1.3

200.98

225.70

u/ml

0.37

3263

16655

Other external causes of accidental injury

3838

14281

1.37

62.76

1.3

269.39

236.29

u/ml

0.50

3560

13202

Diseases of middle ear and mastoid

2585

14975

1.45

62.74

1.4

1.3

306.47

244.90

u/ml

0.72

2401

13836

Inflammatory diseases of female pelvic organs

2844

15408

1.43

62.47

1.3

212.15

187.97

u/ml

0.25

2624

14236

Visual disturbances and blindness

1910

12839

1.53

62.15

1.4

1.3

248.28

234.85

u/ml

0.17

1759

11824

Oter anti-inflammatory and antirheumatic agents, non-steroids

750

2097

2.04

61.60

1.3

197.21

342.08

u/ml

2.73

688

1935

Rosacea

544

2582

2.25

61.54

1.4

1.3

193.87

186.44

u/ml

0.09

516

2390

Dentinal caries

919

5155

1.84

61.31

1.5

1.3

282.42

283.39

u/ml

0.01

850

4789

Osteopathies and chondropathies

2035

13155

1.50

61.18

1.4

1.3

274.63

233.60

u/ml

0.36

1892

12129

Gonarthrosis

2360

9334

1.48

61.00

1.3

206.39

269.01

u/ml

1.90

2175

8677

Infection due to other mycobacteria

116

221

6.36

60.71

2.0

1.2

162.13

281.89

u/ml

0.53

109

205

Mouth breathing

1575

10214

1.59

60.68

1.4

1.3

249.28

260.06

u/ml

0.13

1472

9495

Polyarthrosis

681

3349

2.03

60.45

1.4

1.2

159.95

213.05

u/ml

1.50

621

3073

Atypical mycobacterium lung infection

161

7.70

60.21

2.1

1.2

181.73

280.55

u/ml

0.29

147

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2238

15541

1.47

60.13

1.4

1.3

293.07

226.57

u/ml

0.69

2076

14336

Carpal tunnel syndrome

2325

14722

1.46

59.65

1.3

200.36

230.32

u/ml

0.84

2168

13602

Pulmonary heart disease, diseases of pulmonary circulation

1008

5870

1.77

59.57

1.4

1.3

208.63

248.00

u/ml

0.71

935

5377

Infections of the skin and subcutaneous tissue

2309

16158

1.46

59.48

1.4

1.3

477.45

240.73

u/ml

6.01

2174

14954

Syncope and collapse

1490

8448

1.60

59.29

1.3

252.91

255.10

u/ml

0.03

1368

7784

Special screening examination for infectious and parasitic diseases

1111

4915

1.74

59.13

1.3

1.2

212.95

238.68

u/ml

0.47

1009

4546

Hypertensive diseases

3377

14125

1.38

58.73

1.3

245.55

229.63

u/ml

0.30

3153

13135

Hypertension

3371

14107

1.38

58.35

1.3

246.21

228.91

u/ml

0.33

3147

13118

Injuries to the ankle and foot

3029

20332

1.39

58.28

1.3

252.87

247.01

u/ml

0.08

2824

18837

Accidents

3799

14281

1.35

58.10

1.3

262.08

236.29

u/ml

0.36

3522

13202

Deforming dorsopathies

1092

6558

1.72

58.02

1.3

189.14

264.99

u/ml

1.77

1003

6038

Covid-19 suspected case

1021

6052

1.76

57.86

1.4

1.3

169.90

231.63

u/ml

1.68

933

5607

Bacterial infection, other or unspecified

1683

10047

1.55

57.73

1.5

1.3

306.71

231.79

u/ml

1.53

1535

9249

Fenamates

614

2032

2.12

57.39

1.3

165.90

296.98

u/ml

2.52

566

1883

Paracetamol of NSAID medication

819

2185

1.94

57.00

1.3

237.60

394.05

u/ml

2.13

755

2022

Enthesopathies of lower limb, excluding foot

878

5004

1.82

56.57

1.4

1.3

169.44

253.86

u/ml

2.12

820

4625

Any mental disorder

4776

18611

1.30

56.20

1.3

272.67

234.14

u/ml

0.75

4376

17306

Occupational exposure to risk-factors

196

592

3.76

55.72

1.5

1.2

226.30

239.06

u/ml

0.06

180

543

Congenital malformations of the respiratory system

149

381

4.86

55.48

2.0

1.4

122.74

211.26

u/ml

0.71

138

345

Intracranial trauma

2320

12258

1.44

55.05

1.3

254.51

267.52

u/ml

0.17

2145

11337

Suppurative and unspecified otitis media

1714

10234

1.53

54.81

1.4

1.3

330.54

243.62

u/ml

0.73

1592

9447

Nausea and vomiting

979

5705

1.74

54.39

1.4

1.3

210.68

281.21

u/ml

0.98

904

5222

Dental caries 1 and operation codes

3397

13001

1.36

54.22

1.3

239.28

245.51

u/ml

0.11

3113

12077

Heart failure and antihypertensive medication

855

3155

1.85

54.18

1.3

286.19

245.04

u/ml

0.43

789

2898

Conjunctivitis (acute, non atopic)

1176

7316

1.66

53.99

1.4

1.3

412.48

198.80

u/ml

4.56

1092

6763

Migraine without aura and triptan purchases

860

4974

1.82

53.72

1.4

1.3

265.91

190.26

u/ml

0.29

807

4619

Diseases of salivary glands

766

4272

1.87

53.23

1.4

1.3

251.92

222.57

u/ml

0.26

713

3961

Propionic acid derivatives

1192

3632

1.69

52.91

1.3

277.55

376.68

u/ml

1.27

1105

3353

External causes of morbidity and mortality

3101

11473

1.38

52.81

1.3

226.98

232.36

u/ml

0.10

2867

10584

Injury, poisoning and certain other consequences of external causes

2570

9231

1.42

52.51

1.3

215.01

228.96

u/ml

0.29

2390

8516

Impingement syndrome of shoulder

887

5184

1.77

52.16

1.3

141.58

245.31

u/ml

6.37

829

4783

Gingivitis and periodontal diseases

3630

14236

1.34

51.37

1.3

261.40

248.46

u/ml

0.16

3331

13192

Chronic gastritis

851

4929

1.78

51.32

1.3

191.10

249.18

u/ml

1.25

783

4497

Psychiatric diseases

4687

18438

1.29

51.29

1.3

272.99

235.16

u/ml

0.72

4293

17148

Artrosis, including avohilmo

3350

13838

1.35

51.12

1.3

218.98

251.50

u/ml

0.88

3111

12876

Dental caries 3 and operation codes

3590

13980

1.34

51.04

1.3

235.64

243.57

u/ml

0.15

3296

12976

Menorrhagia

1616

5933

1.55

51.01

1.3

136.51

194.48

u/ml

3.64

1505

5483

Other reaction to severe stress, and adjustment disorders

1662

11330

1.51

50.94

1.4

1.3

212.51

222.54

u/ml

0.16

1542

10523

Tonsillectomy and adenotomy

2811

14499

1.38

50.84

1.4

1.3

280.09

233.03

u/ml

0.50

2626

13467

Exposure to other specified factors

2994

21106

1.36

50.56

1.4

1.3

262.27

250.15

u/ml

0.20

2796

19518

Other diseases of lip and oral mucosa

599

3144

1.99

50.45

1.4

1.3

199.55

230.39

u/ml

0.47

547

2904

Cervicocranial syndrome

447

2117

2.23

50.36

1.4

1.3

151.02

196.33

u/ml

1.00

414

1962

Trochanteric bursitis

517

2584

2.10

50.28

1.3

159.04

205.69

u/ml

1.10

474

2352

Benign neoplasm of colon, rectum, anus and anal canal

1878

11787

1.47

50.27

1.3

208.36

244.41

u/ml

0.63

1722

10885

Benign neoplasm: Colon

1555

10234

1.52

50.26

1.4

1.3

220.63

244.57

u/ml

0.29

1423

9408

Bullous disorders

255

945

2.93

50.08

1.5

1.2

614.25

220.93

u/ml

4.00

239

863

Other contact dermatitis

362

1579

2.44

50.04

1.4

1.3

587.60

136.92

u/ml

2.80

338

1454

Other gastritis (incl. Duodenitis)

745

4200

1.83

49.58

1.4

1.3

287.74

263.96

u/ml

0.25

685

3866

Condition for Implicit Sepsis (Organ dysfunction codes)

3141

17219

1.35

49.57

1.4

1.3

249.16

245.68

u/ml

0.05

2895

15962

Other skin changes

602

3186

1.97

49.53

1.3

278.28

221.29

u/ml

0.44

548

2917

Other specified/unspecified arthritis

1003

6140

1.69

49.50

1.4

1.3

236.31

266.00

u/ml

0.30

929

5664

Other necrotizing vasculopathies (FG)

247

903

2.94

49.50

1.5

1.2

149.21

224.41

u/ml

1.20

232

829

Excessive, frequent and irregular menstruation

1916

7374

1.48

49.40

1.3

140.90

210.27

u/ml

5.97

1780

6800

Pulmonary embolism

903

5378

1.73

49.27

1.4

1.3

194.99

243.97

u/ml

0.92

833

4927

Benign neoplasms

4204

18331

1.30

49.22

1.3

181.63

270.32

u/ml

8.15

3900

16971

Pemphigoid

133

334

4.49

49.11

1.3

1.2

570.69

185.20

u/ml

3.30

124

301

Rash and other nonspecific skin eruption

438

2090

2.23

48.81

1.5

1.3

417.88

200.77

u/ml

1.94

411

1931

Osteoporosis

768

4177

1.81

48.75

1.5

1.3

200.26

201.44

u/ml

0.01

706

3776

Sulfasalazine

991

6064

1.68

48.74

1.3

1.2

147.18

176.48

u/ml

0.67

921

5543

Sicca syndrome [Sjögren]

400

1848

2.32

48.63

1.3

1.2

137.31

175.38

u/ml

0.67

353

1693

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2051

14626

1.43

48.55

1.4

1.3

285.18

230.01

u/ml

0.49

1900

13501

Pulmonary heart disease

903

5403

1.72

48.43

1.4

1.3

194.99

242.97

u/ml

0.89

833

4952

Other disorders of teeth and supporting structures

770

4419

1.81

48.42

1.4

1.3

258.39

259.93

u/ml

0.01

711

4094

Gonarthrosis [arthrosis of knee](FG)

2727

11840

1.38

48.23

1.3

201.40

256.63

u/ml

1.98

2519

11021

Septicaemia

1247

7767

1.58

47.78

1.5

1.3

358.41

230.19

u/ml

2.51

1136

7137

Bullous pemphigoid

108

236

5.21

47.68

1.4

1.2

531.74

185.75

u/ml

3.15

101

213

Acute suppurative otitis media

1299

7963

1.58

47.64

1.5

1.3

321.30

252.48

u/ml

0.39

1200

7358

Other necrotizing vasculopathies

288

1162

2.66

47.47

1.5

1.2

188.73

211.47

u/ml

0.17

271

1068

Any operation in hilmo

210

319

3.48

47.32

1.2

1.1

345.26

258.80

u/ml

0.29

193

283

Reimbursement for rheumatic diseases

2206

15974

1.41

47.26

1.3

158.15

234.49

u/ml

5.75

2035

14773

Subjective visual disturbances

939

5744

1.69

46.88

1.3

176.49

196.48

u/ml

0.39

860

5277

Candidiasis

570

3027

1.98

46.88

1.5

1.3

199.02

193.86

u/ml

0.06

528

2789

Genitourinary diseases

2646

9741

1.38

46.75

1.3

302.96

294.74

u/ml

0.10

2442

9063

Pleural plaque

269

1054

2.67

46.34

1.3

329.92

327.25

u/ml

0.01

250

945

Other arthritis (FG)

1168

7545

1.59

46.05

1.3

245.01

253.99

u/ml

0.08

1082

6964

Allergic contact dermatitis due to drugs in contact with skin

150

434

4.02

46.02

1.6

1.2

578.76

209.14

u/ml

1.71

143

398

Vasomotor rhinitis (mode)

338

1492

2.44

45.90

1.5

1.2

208.01

200.75

u/ml

0.03

315

1377

Methotrexate

521

2693

2.01

45.81

1.3

1.2

168.80

159.13

u/ml

0.11

480

2455

Injuries to the knee and lower leg

4875

22394

1.26

45.76

1.4

1.3

228.07

252.53

u/ml

0.83

4548

20685

Anti-inflammatory and antirheumatic products, non-steroids

1157

3633

1.63

45.71

1.3

257.58

376.60

u/ml

2.18

1076

3354

Other epidermal thickening

217

779

3.06

45.56

1.3

1.2

286.59

238.59

u/ml

0.29

207

711

Implicit fungal Sepsis

173

547

3.52

45.45

1.9

1.2

326.21

232.06

u/ml

0.52

155

503

Exclusions for E4_PCOS_BROAD

747

4343

1.80

45.45

1.7

1.3

319.93

224.54

u/ml

0.71

702

4041

Fungal Sepsis

183

599

3.38

45.29

1.9

1.2

336.90

225.13

u/ml

0.69

164

551

1055

6262

1.62

45.14

1.3

239.64

243.81

u/ml

0.04

962

5688

Abnormal findings on examination of blood, without diagnosis

1433

9056

1.51

45.02

1.4

1.3

323.75

266.81

u/ml

0.47

1337

8369

Chronic periapical parodontitis

739

4281

1.79

45.01

1.5

1.3

284.11

272.10

u/ml

0.11

691

3973

Hypothyroidism, drug reimbursement

711

2867

1.84

44.92

1.3

138.31

214.54

u/ml

2.94

659

2692

Explicit Sepsis

1358

8713

1.53

44.76

1.5

1.3

351.36

252.03

u/ml

1.55

1239

8019

Herpesviral [herpes simplex] infections

511

2660

2.03

44.75

1.7

1.3

1079.48

197.29

u/ml

3.12

469

2463

Diseases of the digestive system

1488

10145

1.50

44.46

1.4

1.3

314.30

242.77

u/ml

1.00

1379

9340

Endometriosis

1605

6558

1.50

43.65

1.3

150.09

196.83

u/ml

1.85

1477

6066

Dental operations, only avohilmo

2516

9497

1.38

43.55

1.3

222.86

263.47

u/ml

1.22

2307

8808

TMD related operations

751

4433

1.77

43.48

1.4

1.3

137.00

203.50

u/ml

3.75

701

4108

Benign neoplasms

3568

15717

1.31

43.24

1.3

181.84

259.67

u/ml

6.04

3313

14604

Lateral epicondylitis

554

2989

1.94

43.17

1.3

189.68

215.18

u/ml

0.31

523

2763

Other septicaemia

1085

6848

1.59

43.10

1.5

1.3

381.12

227.99

u/ml

2.76

991

6288

Dental caries 2 and operation codes

3273

20201

1.31

42.78

1.3

234.71

242.08

u/ml

0.14

3017

18746

Other inflammation of eyelid

508

2675

1.99

42.76

1.5

1.3

293.01

212.94

u/ml

0.97

481

2458

DVT of lower extremities and pulmonary embolism

1258

8351

1.54

42.71

1.4

1.3

203.53

243.86

u/ml

0.86

1163

7657

Gout

671

3474

1.80

42.52

1.3

434.82

303.09

u/ml

1.25

605

3212

Other symptoms and signs involving the digestive system and abdomen

627

3530

1.85

42.33

1.4

1.3

178.72

210.19

u/ml

0.48

584

3232

Other disorders of patella

750

4458

1.75

41.91

1.3

240.09

247.67

u/ml

0.05

702

4140

Erysipelas

1697

10936

1.44

41.81

1.4

1.3

561.79

230.80

u/ml

4.87

1565

10113

L04AD Calcineurin inhibitors

477

2491

2.03

41.60

1.5

1.3

726.53

230.13

u/ml

2.62

441

2318

Spondylolisthesis/Spondylolysis

630

3568

1.83

41.56

1.4

1.3

186.60

236.13

u/ml

0.82

585

3280

Lung cancer and mesothelioma

359

1411

2.23

41.32

1.2

1.1

257.37

272.29

u/ml

0.11

325

1271

Hypermobility syndrome

327

1502

2.38

41.11

1.5

1.3

139.44

178.35

u/ml

0.71

306

1403

Other and unspecified tonsillitis

1460

8541

1.49

41.11

1.4

1.2

268.97

240.31

u/ml

0.33

1357

7902

Haemorrhoids and perianal venous thrombosis

892

5546

1.65

41.02

1.3

208.92

242.11

u/ml

0.47

819

5086

Nonsuppurative otitis media

1077

6048

1.59

40.93

1.5

1.3

311.40

268.00

u/ml

0.47

995

5544

Acute pharyngitis

657

3767

1.80

40.85

1.4

1.2

274.22

249.56

u/ml

0.20

619

3496

Abnormal results of function studies

360

1709

2.24

40.71

1.4

1.3

140.45

226.61

u/ml

2.33

335

1570

Metabolic disorders

3564

17396

1.29

40.63

1.4

1.3

223.55

247.83

u/ml

0.71

3289

16137

Non-selective monoamine reuptake inhibitors

1342

8875

1.50

40.58

1.3

219.82

223.36

u/ml

0.03

1235

8191

Symptoms and signs concerning food and fluid intake

388

1895

2.15

40.20

1.5

1.3

413.81

253.56

u/ml

0.45

364

1744

Dental caries 1

2948

11515

1.33

39.99

1.3

228.29

238.19

u/ml

0.21

2712

10711

Dental caries, including avohilmo

2944

11507

1.33

39.80

1.3

227.93

238.29

u/ml

0.23

2708

10704

Hernia of abdominal wall, postoperative

597

3369

1.83

39.76

1.3

1.2

206.26

221.87

u/ml

0.17

560

3132

Common variable immunodeficiency

113

7.90

39.62

2.2

1.2

100.37

323.77

u/ml

0.52

101

Disorders of sclera, cornea, iris and ciliary body

2001

14720

1.39

39.55

1.4

1.3

406.97

226.83

u/ml

2.28

1848

13614

Dental caries 2

3299

20362

1.29

39.49

1.3

231.47

242.87

u/ml

0.24

3036

18903

Dental caries 3

3185

12605

1.31

39.27

1.3

227.06

236.20

u/ml

0.20

2927

11712

Heartburn

406

2038

2.09

39.22

1.3

1.2

123.81

213.67

u/ml

3.82

377

1869

Use of hypnotics and sedatives

4167

19346

1.26

39.11

1.4

1.3

247.64

234.49

u/ml

0.18

3833

17991

5-aminosalicylic acid

756

4577

1.70

39.03

1.3

1.2

245.85

179.90

u/ml

0.69

702

4198

Heart failure,strict

1416

7027

1.48

38.86

1.3

297.65

269.87

u/ml

0.39

1313

6424

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1988

9193

1.40

38.85

1.3

163.18

234.50

u/ml

3.56

1845

8563

Nonorganic sleeping disorders, excluding more controls

767

4686

1.70

38.68

1.3

175.04

202.55

u/ml

0.41

706

4339

Budesonide

485

2597

1.94

38.53

1.4

1.2

190.42

174.41

u/ml

0.17

449

2376

Venous thromboembolism

1669

11605

1.42

38.41

1.4

1.3

199.15

236.59

u/ml

1.08

1536

10691

Other disorders of ear

3361

17622

1.29

38.33

1.4

1.3

195.25

261.18

u/ml

3.30

3083

16353

Dental pulpitis 4

4473

18806

1.25

38.25

1.3

250.72

246.75

u/ml

0.07

4105

17432

Dental pulpitis 2

2644

10254

1.34

38.25

1.3

216.45

239.95

u/ml

0.62

2428

9541

Diseases of pulp and periapical tissues, including avohilmo

4468

18785

1.25

38.24

1.3

251.14

246.48

u/ml

0.08

4101

17412

Dental pulpitis 1

4473

18811

1.25

38.23

1.3

251.06

246.69

u/ml

0.07

4105

17437

Other disorders involving the immune mechanism, not elsewhere classified

170

594

3.19

37.88

2.3

1.3

521.29

247.13

u/ml

0.67

152

552

Skin changes due to chronic exposure to nonionizing radiation

941

5707

1.59

37.72

1.3

221.85

243.42

u/ml

0.22

857

5186

Bleeding

2756

15439

1.32

37.68

1.4

1.3

256.43

259.83

u/ml

0.05

2554

14283

Falls/tendency to fall

4826

19742

1.24

37.62

1.3

239.55

253.39

u/ml

0.30

4479

18266

Psoriasis

1031

6786

1.56

37.56

1.3

350.46

231.07

u/ml

2.25

974

6277

Disorders of vestibular function (Vertigo)

1512

10635

1.44

37.51

1.3

166.19

231.00

u/ml

2.48

1399

9784

Congenital malformations, deformations and chromosomal abnormalities

2517

18480

1.33

37.50

1.4

1.3

217.76

251.11

u/ml

0.65

2336

17102

Other sleep disorders

410

2098

2.04

37.45

1.4

1.3

408.06

235.58

u/ml

0.32

383

1934

Irregular menses

2237

13671

1.36

37.30

1.4

1.3

210.49

190.48

u/ml

0.17

2089

12654

Acute generalized exanthematous pustulosis

223

901

2.70

37.23

1.6

1.3

398.84

210.59

u/ml

1.24

209

824

Collagenous colitis

367

1817

2.14

37.22

1.6

1.3

257.17

179.53

u/ml

0.80

342

1673

Polyneuropathies and other disorders of the peripheral nervous system

656

3881

1.74

37.05

1.4

1.3

283.81

256.83

u/ml

0.18

607

3569

All influenza (not pneumonia)

560

3174

1.83

36.98

1.5

1.2

279.88

219.40

u/ml

0.79

516

2942

Rheumatoid arthritis

1075

6482

1.54

36.89

1.3

163.59

243.80

u/ml

2.69

999

5981

Persons with potential health hazards related to communicable diseases

1744

12614

1.41

36.85

1.4

1.3

243.58

253.10

u/ml

0.13

1628

11688

Dental caries 3, only avohilmo

3220

12878

1.30

36.79

1.3

223.52

238.65

u/ml

0.39

2958

11971

Dental pulpitis 2, only avohilmo

2682

10476

1.33

36.78

1.3

218.31

239.21

u/ml

0.53

2467

9754

Polyarteritis nodosa and related conditions

239

4.71

36.48

2.2

1.2

241.75

253.98

u/ml

0.03

217

Radiculopathy

513

2839

1.87

36.46

1.4

1.3

150.80

241.96

u/ml

2.78

473

2618

Actinic keratosis

901

5474

1.60

36.43

1.3

226.54

244.74

u/ml

0.17

821

4970

Psoriasis vulgaris

686

4139

1.72

36.26

1.4

1.3

326.08

223.22

u/ml

1.44

648

3831

Paroxysmal tachycardia

868

4655

1.62

36.26

1.3

169.28

245.89

u/ml

3.11

810

4302

Preparation and fitting of bite rail to mouth

608

3569

1.78

36.09

1.4

1.3

133.06

214.07

u/ml

4.19

572

3320

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1339

9273

1.47

36.06

1.4

1.3

287.31

211.21

u/ml

0.48

1232

8602

Generalized skin eruption due to drugs and medicaments

202

793

2.79

35.90

1.6

1.3

424.50

207.13

u/ml

1.35

190

727

Fibroblastic disorders

696

4218

1.69

35.66

1.3

188.16

263.69

u/ml

1.44

647

3856

Dental caries 2, only avohilmo

3225

20178

1.28

35.66

1.3

236.55

242.12

u/ml

0.10

2968

18738

Brachial plexus disorders

443

2381

1.97

35.50

1.3

152.35

196.31

u/ml

0.90

417

2211

Other and unspecified polyneuropathies, also in other diseases

565

3257

1.79

35.10

1.4

1.3

300.73

263.80

u/ml

0.22

525

2980

Dental caries 1, only avohilmo

2970

11829

1.30

35.06

1.3

227.62

240.40

u/ml

0.29

2734

11007

Other diseases of anus and rectum

908

5885

1.58

35.01

1.3

192.82

241.92

u/ml

1.22

834

5407

Other or unspecified common variable immunodeficiency

11.66

34.90

2.3

1.2

59.43

508.08

u/ml

0.58

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1593

11545

1.41

34.59

1.4

1.3

290.42

249.57

u/ml

0.39

1470

10672

Other shoulder lesions

372

1897

2.06

34.51

1.3

1.2

171.10

222.19

u/ml

0.86

341

1748

Cystic fibrosis with pulmonary manifestations

33.09

34.40

3.7

1.2

113.68

1010.37

u/ml

0.55

Noninfectious colitis NAS

528

3012

1.83

34.40

1.5

1.3

252.14

196.02

u/ml

0.67

489

2775

Polycystic ovarian syndrome, consortium definition

3164

15115

1.28

34.27

1.3

205.68

191.25

u/ml

0.16

2937

13939

Chronic kidney disease

745

4617

1.64

34.13

1.4

1.3

376.42

262.90

u/ml

1.03

691

4232

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

157

559

3.13

33.87

2.4

1.3

551.41

249.74

u/ml

0.69

141

520

Sequelae of external causes of morbidity and mortality

824

5283

1.60

33.81

1.4

1.3

330.39

228.10

u/ml

0.40

770

4859

Benign neoplasm: Colon

1543

8505

1.42

33.70

1.4

1.3

221.72

235.67

u/ml

0.15

1413

7900

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

269

1223

2.31

33.70

1.5

1.2

316.98

202.44

u/ml

1.38

252

1120

Renal failure

1130

7050

1.49

33.54

1.4

1.3

357.00

263.03

u/ml

1.21

1040

6476

Diseases of inner ear

1735

12552

1.38

33.21

1.3

164.41

239.83

u/ml

3.89

1605

11563

Injuries to the wrist and hand

3920

23169

1.24

33.19

1.3

268.80

246.42

u/ml

0.39

3635

21448

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

3733

20562

1.25

33.17

1.4

1.3

202.31

249.09

u/ml

2.58

3432

19087

Dislocation, sprain and strain of joints and ligaments at neck level

667

4100

1.69

33.16

1.4

1.3

231.29

220.23

u/ml

0.10

613

3809

Dental pulpitis 4, only avohilmo

4484

19247

1.23

33.15

1.3

253.95

247.52

u/ml

0.11

4104

17852

Benign neoplasm of colon, rectum, anus and anal canal

1810

9556

1.38

33.09

1.3

206.33

234.69

u/ml

0.43

1660

8885

Zoster [herpes zoster]

552

3219

1.77

32.99

1.5

1.3

367.69

205.94

u/ml

1.68

500

2952

Other diseases of oesophagus

312

1514

2.15

32.94

1.5

1.2

290.16

246.13

u/ml

0.17

294

1377

Other viral diseases

1252

8776

1.46

32.94

1.4

1.3

284.27

252.30

u/ml

0.29

1154

8132

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1142

7889

1.49

32.92

1.3

185.88

254.55

u/ml

1.96

1065

7319

Gonarthrosis,primary

2912

14415

1.29

32.89

1.3

222.16

244.34

u/ml

0.43

2670

13383

Ovarian cyst

1650

6934

1.41

32.76

1.3

169.14

201.18

u/ml

0.86

1521

6411

Other enthesopathy of foot (+metatarsalgia)

393

2082

1.98

32.58

1.3

181.33

202.79

u/ml

0.26

362

1910

Conduction disorders

832

4443

1.59

32.56

1.4

1.3

261.96

263.75

u/ml

0.01

766

4083

Acute laryngitis and tracheitis

561

3257

1.76

32.45

1.6

1.2

322.73

273.13

u/ml

0.38

528

3021

Unspecified privation

417

2264

1.93

32.13

1.5

1.3

361.67

216.60

u/ml

1.76

401

2088

Sleep disorders

874

5760

1.57

31.99

1.3

291.07

215.34

u/ml

0.28

805

5322

Injuries to the neck

892

5908

1.56

31.81

1.4

1.3

216.62

229.94

u/ml

0.17

821

5481

Atrial fibrillation and flutter

1120

4988

1.50

31.81

1.3

273.76

260.85

u/ml

0.12

1045

4636

Dental pulpitis 1, only avohilmo

4480

19315

1.22

31.75

1.3

252.95

247.19

u/ml

0.10

4101

17919

Coxarthrosis

1460

7096

1.42

31.74

1.3

313.23

259.04

u/ml

0.53

1330

6572

Other disorders of fluid, electrolyte and acid-base balance

852

5369

1.56

31.66

1.4

1.3

366.97

243.48

u/ml

1.21

782

4922

ILD medications: nintedanib

9.24

31.49

1.3

1.1

167.94

120.29

u/ml

0.49

Diseases of external ear

1148

7999

1.47

31.45

1.4

1.3

352.14

259.00

u/ml

0.96

1055

7374

Transport accidents

1788

11853

1.36

31.30

1.4

1.3

236.01

238.02

u/ml

0.03

1670

10938

Other disorders of skin and subcutaneous tissue, not elsewhere classified

482

2751

1.82

31.23

1.4

1.3

340.36

214.08

u/ml

0.86

435

2532

Pneumonia due to other infectious organisms, not elsewhere classified

144

510

3.07

31.04

2.2

1.2

355.71

216.50

u/ml

0.47

134

470

Hyperlipidaemia, other/unspecified

1041

6731

1.49

31.03

1.3

232.33

268.40

u/ml

0.66

953

6168

Speech therapy

900

6003

1.54

30.87

1.4

1.3

170.70

224.92

u/ml

1.82

847

5509

Ganglion

807

5283

1.57

30.29

1.3

209.02

224.09

u/ml

0.17

753

4864

Adhesive capsulitis of shoulder

550

3284

1.73

30.17

1.3

194.66

222.70

u/ml

0.29

512

3005

Hypersensitivity pneumonitis due to organic dust

273

4.01

30.17

1.8

1.2

145.17

152.91

u/ml

0.05

242

Universal erythroderma, KELA reimbursement

222

4.38

30.11

1.9

1.3

3380.02

214.63

u/ml

3.83

198

Melanocytic naevi

1102

7695

1.47

30.04

1.3

180.48

225.04

u/ml

1.00

1038

7099

Intracranial injury

1997

14763

1.33

30.03

1.3

249.68

269.44

u/ml

0.26

1837

13625

Benign paroxysmal vertigo

909

6110

1.53

30.01

1.3

148.18

220.41

u/ml

4.41

833

5589

Other menopausal disorders

1107

4390

1.49

29.92

1.3

110.86

189.84

u/ml

6.27

1019

4060

Neoplasms

3519

15304

1.25

29.87

1.4

1.3

256.67

261.73

u/ml

0.05

3256

14212

Other and unspecified anaemias

1113

7511

1.46

29.82

1.4

1.3

485.08

227.16

u/ml

3.03

1024

6874

Inflammatory bowel disease

1200

8519

1.44

29.74

1.3

198.39

249.25

u/ml

0.85

1111

7908

Post-traumatic stress disorder

424

2381

1.88

29.70

1.4

1.3

151.58

208.60

u/ml

1.61

382

2218

Lichen planus, including avohilmo

603

3709

1.68

29.66

1.3

292.82

194.47

u/ml

1.43

552

3396

Benzodiazepine use

3790

22177

1.23

29.53

1.3

249.35

241.00

u/ml

0.10

3473

20595

Heart failure, strict

1468

7687

1.39

29.48

1.3

303.89

269.23

u/ml

0.52

1360

7013

Other anaemias

1122

7584

1.45

29.37

1.4

1.3

483.99

226.71

u/ml

3.06

1033

6942

Presence of other functional implants

1604

8389

1.37

29.28

1.3

262.51

253.81

u/ml

0.13

1456

7719

Lichen simplex chronicus

147

543

2.93

29.25

1.5

1.2

402.42

160.96

u/ml

1.37

134

493

Superficial injury of lower leg

919

6229

1.52

29.24

1.3

236.80

239.60

u/ml

0.02

858

5743

Obesity, other/unspecified

1320

9559

1.41

29.21

1.4

1.3

239.44

223.29

u/ml

0.17

1235

8859

Behavioural syndromes associated with physiological disturbances and physical factors

1341

9738

1.41

29.14

1.3

257.10

218.79

u/ml

0.21

1241

8977

Other disorders of veins

1366

9945

1.40

28.97

1.3

193.18

231.51

u/ml

0.85

1269

9188

Other bacterial intestinal infections

572

3489

1.69

28.92

1.5

1.3

277.52

209.57

u/ml

0.92

524

3209

Lichen ruber planus, wide definition including periferal and oral lichen planus

692

4426

1.61

28.90

1.3

267.95

200.52

u/ml

0.99

637

4055

Deposits [accretions] on teeth

307

1508

2.08

28.85

1.6

1.3

183.83

281.34

u/ml

1.56

289

1398

Correction of physiology of bite - demanding therapy visit

337

1783

2.01

28.65

1.5

1.3

150.06

199.14

u/ml

1.17

313

1654

Ischaemic heart disease, wide definition

2393

11707

1.30

28.64

1.4

1.3

235.73

263.66

u/ml

0.56

2201

10841

Hyperkinetic disorders, excluding more controls

506

2929

1.76

28.61

1.4

1.3

278.40

261.98

u/ml

0.11

467

2733

Plantar fascial fibromatosis

368

1992

1.93

28.61

1.2

1.3

105.28

201.01

u/ml

4.66

337

1829

Osteoporosis with pathological fracture (FG)

205

891

2.42

28.61

1.6

1.2

198.97

136.94

u/ml

0.67

191

813

Hernia

3415

18900

1.24

28.52

1.3

255.23

244.37

u/ml

0.16

3167

17496

Other pulmonary heart/vessel disease

160

623

2.73

28.47

1.5

1.2

294.51

261.69

u/ml

0.16

153

564

Other specified/unspecified systemic involvement of connective tissue

264

1286

2.19

28.31

1.4

1.3

213.45

185.56

u/ml

0.22

240

1176

Personality disorders, excluding more controls

1063

7456

1.46

28.29

1.3

282.26

221.83

u/ml

0.27

963

6945

Aplastic and other anaemias

1215

8238

1.42

28.27

1.4

1.3

464.41

227.39

u/ml

3.02

1114

7547

Other and unspecified iron deficiency

1034

7213

1.46

28.08

1.4

1.3

254.48

231.51

u/ml

0.30

953

6624

Bacterial intestinal infections, IBD co-morbidities

575

3541

1.67

28.01

1.5

1.3

279.63

207.02

u/ml

1.03

526

3266

Other and unspecified nerve root and plexus disorders, also in other diseases

655

4170

1.62

27.93

1.4

1.3

170.81

229.12

u/ml

1.71

601

3857

Otitis externa

805

5365

1.54

27.93

1.4

1.3

322.63

228.63

u/ml

0.73

740

4960

TMD related pain

198

871

2.50

27.84

1.4

1.3

144.22

197.60

u/ml

0.70

185

810

Metatarsalgia

356

1924

1.93

27.84

1.3

159.05

202.35

u/ml

0.68

328

1765

Endometriosis of pelvic peritoneum

726

4680

1.58

27.84

1.4

1.3

128.74

183.17

u/ml

1.63

665

4351

Symptoms and signs involving the urinary system

2509

15368

1.28

27.80

1.3

244.46

246.97

u/ml

0.03

2321

14207

Disorders of ocular muscles, binocular movement, accommodation and refraction

1854

14112

1.33

27.68

1.4

1.3

218.87

249.01

u/ml

0.66

1698

13066

Lung diseases due to external agents

377

2070

1.88

27.61

1.5

1.3

260.34

233.58

u/ml

0.19

336

1891

Melanocytic naevi

1102

7817

1.45

27.60

1.3

180.48

210.94

u/ml

0.70

1038

7247

Other and unspecified follicular disorders

185

789

2.54

27.58

1.5

1.3

324.86

251.38

u/ml

0.37

178

730

Atrial fibrillation and flutter with reimbursement

819

3459

1.55

27.50

1.3

263.32

247.40

u/ml

0.13

761

3199

Mixed connective tissue disease

286

1450

2.10

27.49

1.4

1.3

186.69

181.06

u/ml

0.04

257

1331

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

3463

18485

1.23

27.46

1.3

198.88

246.84

u/ml

2.36

3195

17170

Contact with and exposure to communicable diseases

1454

10772

1.38

27.36

1.4

1.3

216.55

240.07

u/ml

0.37

1349

9970

Flat foot [pes planus] (acquired)

341

1829

1.95

27.28

1.4

1.2

194.02

203.79

u/ml

0.06

303

1688

Unspecified/other endometriosis

453

2657

1.79

27.20

1.3

124.97

188.93

u/ml

2.27

418

2465

Allergic colitis

172

723

2.68

27.17

1.8

1.3

666.91

317.18

u/ml

1.26

162

667

Disorders of muscles

359

1959

1.91

27.14

1.3

165.78

231.12

u/ml

1.30

335

1799

Gout, FINNGEN

671

4312

1.59

27.00

1.3

434.82

278.70

u/ml

1.67

605

3950

ILD medications: pirfenidone

6.27

26.97

1.1

216.85

124.65

u/ml

1.00

Other medical care

1200

8445

1.41

26.90

1.5

1.3

441.89

232.79

u/ml

3.19

1115

7741

Generalized anxiety disorder

684

4449

1.59

26.83

1.4

1.3

244.54

214.71

u/ml

0.24

629

4125

All-cause Heart Failure

1425

7552

1.38

26.81

1.3

310.68

271.00

u/ml

0.60

1320

6893

Iron deficiency anaemia

1289

9327

1.39

26.69

1.4

1.3

243.86

224.97

u/ml

0.29

1190

8566

Nonorganic sleeping disorders

767

5116

1.55

26.68

1.3

175.04

217.44

u/ml

0.71

706

4749

Inflammatory disease of uterus

641

4121

1.62

26.65

1.4

1.3

135.30

168.91

u/ml

0.94

588

3804

Other and unspecified vasculitis limited to skin

115

395

3.22

26.47

1.6

1.2

282.50

265.15

u/ml

0.06

109

358

Atopic conjunctivitis

219

1021

2.30

26.43

1.5

1.2

948.20

195.50

u/ml

0.96

203

943

Other diseases of pericardium

158

636

2.64

26.31

1.5

1.3

163.64

277.33

u/ml

1.38

152

587

Panic disorder

663

4302

1.60

26.29

1.3

390.30

206.68

u/ml

0.59

607

4000

Missing teeth due to accident, extraction or parodontitis

374

2087

1.86

26.26

1.5

1.3

186.70

238.17

u/ml

0.69

345

1926

Otitis media, unspecified

537

3052

1.69

26.15

1.4

1.3

255.56

280.78

u/ml

0.19

500

2808

Otalgia

334

1813

1.94

26.11

1.4

1.3

172.45

225.61

u/ml

0.85

305

1677

Other/unspecified synovitis and tenosynovitis

407

2333

1.81

26.09

1.4

1.3

171.63

217.92

u/ml

0.69

386

2138

Keratitis

1224

8915

1.40

26.07

1.4

1.3

543.80

221.83

u/ml

2.75

1120

8220

Artificial joint operation, meniscal resection

2999

16211

1.24

26.04

1.3

223.63

257.35

u/ml

0.93

2744

15042

Other disorders of eyelid

1221

8570

1.40

26.02

1.3

338.71

228.94

u/ml

0.66

1107

7847

Primary_lymphoid and hematopoietic malignant neoplasms

674

4383

1.58

25.98

1.5

1.3

515.42

251.51

u/ml

0.87

568

4040

Acute bronchiolitis

334

1630

1.96

25.88

1.6

1.3

422.14

369.89

u/ml

0.26

309

1510

Other viral diseases, not elsewhere classified

756

5052

1.54

25.73

1.4

1.3

288.24

243.23

u/ml

0.38

702

4696

Ischemic heart diseases

2421

12033

1.28

25.67

1.4

1.3

221.75

265.21

u/ml

1.35

2229

11145

Fissure and fistula of anal and rectal regions

805

5453

1.51

25.60

1.3

155.43

255.17

u/ml

4.33

748

5044

Other extrapyramidal and movement disorders in other diseases

692

4548

1.56

25.56

1.3

139.55

224.93

u/ml

5.02

641

4189

Cellulitis

735

4895

1.54

25.55

1.4

1.3

308.22

226.54

u/ml

1.58

693

4522

Hallux valgus (acquired)

1139

5905

1.42

25.49

1.3

182.65

214.98

u/ml

0.45

1051

5443

Recurring oral aphthae, including avohilmo

506

3103

1.69

25.45

1.3

138.13

215.50

u/ml

2.88

465

2861

Cholecystectomy

2404

16979

1.27

25.45

1.4

1.3

186.33

225.73

u/ml

1.82

2229

15704

Other follicular disorders

308

1646

1.97

25.28

1.4

1.3

357.52

215.27

u/ml

1.04

293

1529

Tinnitus

757

5085

1.53

25.21

1.4

1.3

172.01

253.13

u/ml

2.50

689

4684

Disorders of gallbladder, biliary tract and pancreas

3528

18832

1.22

25.21

1.4

1.3

197.81

241.51

u/ml

2.14

3275

17450

Angina pectoris

1651

8455

1.34

25.16

1.4

1.3

208.93

264.08

u/ml

1.38

1515

7776

Gout, idiopatic and unspecified

574

3623

1.62

25.10

1.3

458.98

267.29

u/ml

1.90

522

3324

Nutritional anaemias

1468

10741

1.35

25.06

1.4

1.3

313.48

223.05

u/ml

1.23

1358

9884

Benign neoplasm: Colon, unspecified

660

4309

1.57

25.01

1.3

225.23

243.18

u/ml

0.24

605

3951

Pain associated with micturition

423

2486

1.77

24.99

1.3

188.78

205.55

u/ml

0.14

392

2296

Benign neoplasm of other and ill-defined parts of digestive system

544

3405

1.65

24.96

1.4

1.3

189.51

205.95

u/ml

0.16

507

3123

Ocular pain

344

1912

1.89

24.95

1.4

1.3

217.03

199.19

u/ml

0.08

321

1764

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1074

7715

1.42

24.95

1.4

1.3

289.76

254.30

u/ml

0.53

1002

7145

Benign neoplasm: Colon, unspecified

660

4290

1.57

24.93

1.3

225.23

230.01

u/ml

0.06

605

3936

Striking against or struck by other objects

1192

8709

1.40

24.90

1.4

1.3

333.90

283.98

u/ml

0.44

1107

8076

Other disorders of eye and adnexa

538

3370

1.66

24.87

1.4

1.3

219.45

207.39

u/ml

0.08

502

3123

Other hammer toe(s) (acquired)

490

2794

1.69

24.81

1.4

1.2

248.84

204.44

u/ml

0.28

461

2545

Excessive attrition of teeth

1685

6953

1.34

24.79

1.3

221.40

230.91

u/ml

0.11

1560

6454

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

728

4889

1.54

24.70

1.3

191.30

182.74

u/ml

0.06

677

4519

Insomnia

634

4132

1.59

24.66

1.4

1.3

344.48

215.51

u/ml

0.37

580

3842

Seropositive rheumatoid arthritis

797

5414

1.50

24.65

1.3

152.92

211.32

u/ml

2.34

738

4974

Coeliac disease

488

2992

1.70

24.65

1.4

1.3

228.75

210.78

u/ml

0.18

452

2767

Other disorders of bone

753

5083

1.52

24.64

1.4

1.3

349.21

230.01

u/ml

0.43

712

4720

Sequelae with surgical and medical care as external cause

613

3960

1.59

24.54

1.4

1.3

346.32

222.07

u/ml

0.36

577

3633

Selective deficiency of immunoglobulin A [IgA]y

6.82

24.44

1.6

1.2

154.39

371.08

u/ml

0.38

Disorders of lens

2115

10486

1.29

24.37

1.4

1.3

298.00

231.92

u/ml

1.91

1927

9715

Secondary right heart disease

140

552

2.69

24.36

1.5

1.2

325.47

264.55

u/ml

0.28

133

498

Viral pneumonia (known virus, not influenza)

106

364

3.19

24.35

1.6

1.3

395.17

256.15

u/ml

0.38

331

Sensorineural hearing loss

2291

12754

1.27

24.28

1.3

209.26

256.13

u/ml

1.34

2095

11794

Type of accident

987

7028

1.44

24.17

1.4

1.3

279.25

242.31

u/ml

0.57

919

6497

Lichen planus

419

2489

1.74

23.75

1.3

311.82

188.34

u/ml

1.32

386

2284

Coxarthrosis [arthrosis of hip](FG)

1545

8485

1.33

23.60

1.3

304.86

251.33

u/ml

0.56

1404

7858

Polyuria

642

4222

1.56

23.60

1.3

260.44

254.98

u/ml

0.04

592

3890

Melanocytic naevi, other sites/unspecified

321

1778

1.90

23.53

1.2

1.3

124.35

222.06

u/ml

2.23

301

1651

Peritonsillar abscess

686

4578

1.53

23.49

1.3

1.2

260.16

211.26

u/ml

0.48

627

4235

Dermatophytosis

413

2451

1.74

23.46

1.4

1.3

561.45

222.13

u/ml

1.95

383

2245

Cardiac murmurs and other cardiac sounds

335

1854

1.85

23.27

1.4

1.2

274.99

250.26

u/ml

0.09

306

1708

Primary_lymphoid and hematopoietic malignant neoplasms

674

4489

1.54

23.26

1.5

1.3

515.42

246.45

u/ml

0.90

568

4137

Other diseases of liver

604

3941

1.58

23.26

1.4

1.3

309.31

220.93

u/ml

0.68

571

3654

Gonarthrosis, primary, with knee surgery

1499

9308

1.33

23.18

1.3

202.16

239.44

u/ml

0.74

1368

8573

Hypo-osmolality and hyponatraemia

457

2779

1.68

23.11

1.3

491.23

235.97

u/ml

1.50

413

2543

Noninflammatory disorders of female genital tract

1941

7631

1.30

22.88

1.3

163.74

214.13

u/ml

2.29

1806

7031

Coagulation defects, purpura and other haemorrhagic conditions

660

4407

1.54

22.80

1.4

1.3

247.31

216.59

u/ml

0.38

600

4075

Conductive and sensorineural hearing loss

2483

13901

1.25

22.80

1.3

207.16

254.55

u/ml

1.51

2275

12865

Cluster headache, wide

174

784

2.37

22.78

1.4

1.3

136.39

228.79

u/ml

1.26

164

725

Disorders of lipoprotein metabolism and other lipidaemias

2617

13354

1.25

22.78

1.3

234.85

248.75

u/ml

0.27

2401

12360

514

3252

1.63

22.77

1.5

1.3

193.63

178.91

u/ml

0.27

468

3010

Melanocytic naevi, other sites/unspecified

321

1798

1.88

22.71

1.2

1.3

124.35

206.86

u/ml

1.75

301

1664

Use of pramipexole

643

4272

1.54

22.62

1.4

1.3

218.85

221.05

u/ml

0.02

597

3905

Hernia of abdominal wall

1380

10463

1.34

22.50

1.3

265.35

251.78

u/ml

0.14

1298

9677

Other bursopathies

390

2302

1.75

22.48

1.3

247.78

245.54

u/ml

0.02

368

2099

Viral and other specified intestinal infections

884

6110

1.45

22.45

1.4

1.3

253.42

288.01

u/ml

0.36

813

5643

Restless leg syndrome

411

2469

1.73

22.44

1.3

155.17

194.07

u/ml

0.84

383

2276

Cluster headache, strict

166

739

2.41

22.42

1.4

1.3

140.85

234.80

u/ml

1.20

156

689

Fall on same level

4663

22303

1.18

22.40

1.3

259.94

247.30

u/ml

0.27

4344

20640

Cholelithiasis

2930

16944

1.23

22.32

1.4

1.3

185.89

231.58

u/ml

2.02

2720

15687

Non-ischemic cardiomyopathy

741

4142

1.50

22.20

1.3

347.13

252.89

u/ml

1.07

687

3774

Valvular heart disease excluding rheumatic fever

1330

7292

1.35

22.17

1.3

232.70

275.05

u/ml

0.85

1212

6718

Vasculitis limited to skin, not elsewhere classified

118

453

2.84

22.08

1.6

1.2

281.71

271.28

u/ml

0.04

112

411

Cutaneous abscess, furuncle and carbuncle

897

6389

1.44

22.01

1.4

1.3

316.14

223.29

u/ml

1.62

841

5929

Hyperhidrosis

146

620

2.54

22.01

1.3

122.45

243.21

u/ml

1.89

137

577

Non-rheumatic valve diseases

1311

7173

1.35

22.00

1.3

234.50

274.89

u/ml

0.78

1193

6607

Disorders of vitreous body and globe

1444

10775

1.33

21.97

1.3

141.36

233.15

u/ml

9.76

1327

9903

Other and unspecified local infections of skin and subcutaneous tissue

337

1929

1.82

21.96

1.5

1.3

726.56

207.53

u/ml

1.97

313

1779

Disorders of vitreous body

1411

10537

1.33

21.95

1.3

143.01

227.17

u/ml

8.49

1296

9681

Other diseases of intestine

348

2005

1.79

21.90

1.5

1.3

358.00

214.18

u/ml

0.51

328

1844

Other congenital malformations

407

2464

1.73

21.89

1.4

1.3

200.90

228.65

u/ml

0.37

374

2291

Localized swelling, mass and lump of skin and subcutaneous tissue

1017

7400

1.40

21.89

1.4

1.3

257.14

228.72

u/ml

0.35

945

6809

Viral pneumonia (unknown virus, not influenza)

251

1314

2.00

21.86

1.5

1.3

191.73

219.59

u/ml

0.29

230

1209

Disorders of parathyroid gland

571

3675

1.57

21.83

1.3

178.63

201.50

u/ml

0.30

531

3350

Injuries to the thorax

1312

9914

1.34

21.82

1.3

256.97

257.19

u/ml

0.00

1209

9155

Diseases of liver

1043

7624

1.39

21.78

1.4

1.3

282.65

259.49

u/ml

0.22

970

7044

Oxycodone

914

6306

1.42

21.76

1.4

1.3

271.81

235.08

u/ml

0.33

832

5800

Cholelithiasis, broad definition with cholecystitis

3027

17208

1.22

21.63

1.4

1.3

189.96

231.96

u/ml

1.82

2810

15929

Benign neoplasm of other and ill-defined parts of digestive system

544

3528

1.59

21.52

1.4

1.3

189.51

214.81

u/ml

0.27

507

3264

Other/unspecified enthesopathies of lower limb, excluding foot

268

1442

1.94

21.42

1.4

1.3

111.74

222.38

u/ml

3.63

254

1336

Other symptoms and signs involving the urinary system

327

1867

1.82

21.38

1.3

158.35

261.19

u/ml

2.31

306

1709

Primary gonarthrosis, bilateral

1379

9188

1.33

21.34

1.3

182.12

238.62

u/ml

2.63

1263

8453

Achilles tendinitis

341

1975

1.79

21.19

1.4

1.3

203.26

198.93

u/ml

0.04

317

1826

Pneumocystosis

239

3.60

21.16

2.3

1.2

197.35

298.17

u/ml

0.40

218

Dislocation, sprain and strain of joints and ligaments of knee

2333

17639

1.25

21.16

1.4

1.3

246.55

248.89

u/ml

0.03

2182

16324

Open wound of lower leg

478

3023

1.63

21.12

1.5

1.3

271.13

247.88

u/ml

0.23

450

2782

Hypertrophy of breast in women and men

780

5474

1.47

21.07

1.3

336.19

176.87

u/ml

0.62

725

5064

Other and unspecified disorders of vitreous body

1172

8720

1.36

21.07

1.3

132.36

222.95

u/ml

9.03

1078

7995

Endometriosis of rectovaginal septum and vagina

309

1748

1.85

21.06

1.4

1.3

196.05

203.87

u/ml

0.04

287

1607

Heart failure and bmi 25plus

881

4295

1.44

21.04

1.3

273.61

274.56

u/ml

0.01

815

3939

Atypical facial pain

212

1065

2.11

20.99

1.4

1.3

118.71

201.66

u/ml

1.44

197

976

Umbilical hernia

834

5915

1.44

20.91

1.3

255.26

257.40

u/ml

0.03

788

5509

Spondylopathies (FG)

521

3372

1.59

20.88

1.4

1.3

243.75

238.03

u/ml

0.03

499

3128

Other/unspecified enthesopathies, not elsewhere classified

282

1551

1.88

20.87

1.3

1.2

226.16

222.45

u/ml

0.03

256

1408

Senile cataract

1801

8786

1.29

20.63

1.3

287.82

238.52

u/ml

1.21

1627

8108

Other and unspecified disorders of white blood cells

160

728

2.34

20.49

1.7

1.3

335.62

226.91

u/ml

0.40

141

667

Acute renal failure

507

3265

1.59

20.49

1.3

393.24

264.99

u/ml

0.84

462

2985

Gastroduodenal ulcer

615

4113

1.52

20.45

1.3

355.60

268.47

u/ml

0.46

575

3764

Respiratory disorders in diseases classified elsewhere

240

3.58

20.44

1.6

1.2

135.37

247.01

u/ml

0.51

214

Ulcerative colitis

875

6289

1.42

20.40

1.3

207.38

226.17

u/ml

0.19

816

5830

Other local infections of skin and subcutaneous tissue

346

2040

1.76

20.30

1.5

1.3

732.10

207.30

u/ml

2.08

321

1880

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

1034

9101

0.73

20.26

1.3

187.39

188.69

u/ml

0.02

932

8446

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

1034

9099

0.73

20.23

1.3

187.39

188.67

u/ml

0.02

932

8444

Crohn disease

507

3292

1.59

20.17

1.3

156.90

217.81

u/ml

1.43

468

3050

Unknown and unspecified causes of morbidity

254

1369

1.93

20.10

1.5

1.2

163.39

219.51

u/ml

0.82

235

1263

Pneumonia due to Streptococcus pneumoniae

156

706

2.33

20.09

1.7

1.2

186.68

201.17

u/ml

0.14

141

650

Adenomyosis (Endometriosis of uterus)

479

3074

1.61

19.99

1.3

141.14

208.22

u/ml

2.51

445

2821

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1160

8744

1.35

19.98

1.4

1.3

173.97

227.22

u/ml

0.95

1089

8053

Other diseases of jaws

254

1375

1.93

19.96

1.3

171.86

203.59

u/ml

0.39

237

1269

Gout, strict definition

405

2492

1.66

19.85

1.3

476.31

280.59

u/ml

1.25

365

2277

Sequelae of injuries, of poisoning and of other consequences of external causes

799

5687

1.44

19.75

1.4

1.3

280.96

241.26

u/ml

0.31

755

5276

Rheumatoid arthritis, including avohilmo

1212

9206

1.34

19.66

1.3

162.99

219.79

u/ml

2.16

1127

8436

Suppurative and necrotic conditions of lower respiratory tract

173

823

2.21

19.62

1.4

1.3

443.85

259.51

u/ml

0.44

161

757

Ulcerative colitis, NAS

522

3432

1.57

19.58

1.3

235.48

223.36

u/ml

0.07

483

3182

Chronic conjunctivitis

141

623

2.44

19.56

1.6

1.2

451.33

205.50

u/ml

1.14

132

570

Stomatitis and related lesions

306

1765

1.80

19.47

1.4

1.3

313.06

233.40

u/ml

0.31

283

1632

Disorders of refraction and accommodation

1028

7621

1.37

19.42

1.4

1.3

204.65

236.54

u/ml

0.55

942

7079

Abnormal involuntary movements

439

2781

1.63

19.38

1.4

1.3

254.23

212.91

u/ml

0.21

408

2552

Seborrhoeic keratosis

604

4091

1.51

19.37

1.3

149.60

204.93

u/ml

1.69

553

3733

Direct fill therapy

503

3294

1.58

19.27

1.7

1.3

163.21

237.15

u/ml

2.04

465

3069

Abnormal findings on diagnostic imaging of other body structures

398

2466

1.67

19.25

1.3

169.31

195.34

u/ml

0.46

352

2263

Spondyloarthritis

604

4098

1.51

19.25

1.4

1.3

235.92

224.98

u/ml

0.07

579

3785

Other metabolic disorders

491

3201

1.58

19.20

1.5

1.3

166.85

193.49

u/ml

0.46

460

2982

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

177

866

2.20

19.09

1.5

1.3

234.53

230.45

u/ml

0.03

168

810

Pure hypercholesterolaemia

2153

11723

1.25

19.06

1.3

223.03

253.04

u/ml

0.82

1984

10844

Weight loss

309

1802

1.78

18.89

1.5

1.3

486.68

226.86

u/ml

0.64

292

1664

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

899

5986

1.40

18.88

1.4

1.3

324.84

274.74

u/ml

0.43

816

5545

Otitis externa, unspecified

409

2570

1.65

18.84

1.3

330.51

213.88

u/ml

0.46

375

2385

Transplanted organ and tissue status

336

2008

1.74

18.82

1.5

1.3

330.44

252.08

u/ml

0.45

308

1865

Extrapyramidal and movement disorders

1009

7507

1.37

18.82

1.3

193.20

230.42

u/ml

0.45

933

6866

Lesion of ulnar nerve

442

2823

1.61

18.78

1.3

259.06

243.89

u/ml

0.08

404

2604

Gout, unspecified

459

2950

1.59

18.76

1.3

456.66

280.41

u/ml

1.28

416

2703

Other cataract

1185

6954

1.34

18.73

1.4

1.3

307.56

226.10

u/ml

1.58

1093

6387

Hallux rigidus

399

2489

1.65

18.63

1.3

1.2

161.13

215.46

u/ml

1.40

374

2275

Mental and behavioural disorders due to tobacco

305

1786

1.78

18.51

1.4

1.3

393.09

213.48

u/ml

1.56

289

1646

Hypertrophy of breast

707

5000

1.46

18.47

1.4

1.3

342.30

168.21

u/ml

0.62

658

4627

N06DA Anticholinesterases

227

3341

0.54

18.45

1.1

1.3

200.96

257.92

u/ml

0.84

193

3024

Use of anticholinesterases

227

3341

0.54

18.45

1.1

1.3

200.96

257.92

u/ml

0.84

193

3024

Wegener granulomatosis

271

3.23

18.40

1.7

1.2

121.13

254.70

u/ml

0.81

245

Polymyalgia rheumatica

310

1816

1.75

18.40

1.4

1.2

284.23

214.55

u/ml

0.61

284

1651

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

152

712

2.30

18.36

1.3

1.2

223.29

214.60

u/ml

0.05

145

665

Other female pelvic inflammatory diseases

607

4176

1.50

18.31

1.4

1.3

170.74

180.75

u/ml

0.14

563

3837

Other CVD (FINNGEN)

301

1364

1.78

18.27

1.4

1.3

328.80

260.37

u/ml

0.25

278

1251

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

194

992

2.06

18.26

1.3

1.2

188.48

222.22

u/ml

0.29

182

911

Other diseases of the digestive system

808

5828

1.41

18.25

1.3

353.03

252.39

u/ml

0.90

749

5361

Pleural effusion

361

2206

1.67

18.23

1.5

1.3

223.61

237.27

u/ml

0.15

331

2005

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

635

7092

0.69

18.22

1.2

1.3

211.80

240.11

u/ml

0.52

563

6560

Smoking dependency

305

1794

1.77

18.22

1.4

1.3

393.09

214.26

u/ml

1.55

289

1654

Chronic periodontitis

424

2699

1.61

18.22

1.4

1.3

326.26

252.90

u/ml

0.68

389

2501

Enterocolitis due to Clostridium difficile

297

1732

1.77

18.01

1.6

1.3

307.68

215.05

u/ml

0.86

265

1586

Other symptoms and signs involving cognitive functions and awareness

1177

8445

1.32

17.88

1.4

1.3

258.01

252.32

u/ml

0.04

1097

7752

Neuralgia and neuritis, unspecified

189

964

2.06

17.87

1.4

1.2

163.43

219.27

u/ml

0.53

176

877

Trigger finger

447

2896

1.58

17.84

1.4

1.3

190.22

216.84

u/ml

0.34

414

2652

Unspecified fall

1560

12297

1.28

17.79

1.3

253.41

252.46

u/ml

0.01

1434

11337

Unspecific neurodegenerative disorder

355

3937

0.61

17.75

1.2

1.3

257.89

260.74

u/ml

0.03

311

3570

Disturbance of activity and attention

491

3223

1.56

17.75

1.4

1.3

276.44

293.06

u/ml

0.11

453

3005

Other problems related to primary support group, including family circumstances

543

3598

1.53

17.60

1.5

1.3

197.85

234.55

u/ml

0.53

493

3351

Other hearing loss

653

4487

1.45

17.59

1.3

157.76

249.39

u/ml

4.29

592

4095

Neuromuscular dysfunction of bladder

285

1658

1.78

17.57

1.5

1.3

272.68

236.62

u/ml

0.18

257

1530

Malignant neoplasm of breast

1105

10416

0.75

17.57

1.3

184.87

191.41

u/ml

0.09

1000

9631

Pacemaker

697

4791

1.43

17.54

1.3

182.96

271.24

u/ml

3.41

638

4369

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

144

667

2.27

17.54

1.5

1.2

154.51

231.60

u/ml

1.15

136

609

Ehlers-Danlos syndrome

239

3.45

17.51

1.4

1.2

215.92

234.62

u/ml

0.05

219

Diseases of arteries, arterioles and capillaries (FINNGEN)

713

3513

1.44

17.50

1.3

326.28

260.22

u/ml

0.94

655

3243

Female genital prolapse

1066

4617

1.36

17.48

1.4

1.3

151.70

191.56

u/ml

1.14

995

4261

Trigeminal neuralgia

216

1163

1.95

17.41

1.4

1.3

145.62

198.59

u/ml

0.57

202

1068

Other abnormal uterine and vaginal bleeding

792

4076

1.41

17.27

1.3

190.20

194.82

u/ml

0.03

721

3741

Alopecia areata

132

600

2.38

17.26

1.4

1.3

531.95

216.73

u/ml

1.49

125

560

Injury of muscle and tendon at shoulder and upper arm level

978

7343

1.35

17.23

1.3

219.28

267.69

u/ml

0.58

899

6785

Chronic ulcer of skin, not elsewhere classified

195

1015

2.00

17.23

1.4

1.3

440.05

244.44

u/ml

0.56

182

939

Disorders of breast

1879

14184

1.25

17.23

1.3

239.87

182.04

u/ml

0.50

1738

13116

Psoriatic arthropathies

330

2008

1.70

17.18

1.3

1.2

210.05

225.90

u/ml

0.12

308

1858

Diseases of male genital organs

1526

6059

1.29

17.17

1.4

1.3

372.63

365.87

u/ml

0.05

1416

5653

Cluster headache, wide,, including avohilmo

223

1223

1.92

17.14

1.3

156.60

227.11

u/ml

0.91

210

1137

Ulcer of lower limb, not elsewhere classified

340

2082

1.67

17.12

1.4

1.3

426.65

239.05

u/ml

2.48

317

1898

Cluster headache, strict, including avohilmo

215

1167

1.95

17.10

1.3

160.85

230.50

u/ml

0.85

202

1087

Myocarditis

175

882

2.07

17.02

1.4

1.2

324.31

283.59

u/ml

0.17

167

811

Viral warts

373

2352

1.64

16.99

1.6

1.3

595.01

203.86

u/ml

0.82

348

2170

Presbycusis

252

1413

1.81

16.98

1.2

157.28

266.83

u/ml

3.41

221

1273

Extreme obesity with alveolar hypoventilation

153

739

2.20

16.94

1.4

1.3

198.03

193.22

u/ml

0.05

144

678

Diplopia

402

2578

1.60

16.88

1.4

1.3

327.13

200.16

u/ml

0.88

373

2371

Anomalies of dental arch relationship, including avohilmo

811

5348

1.40

16.70

1.4

1.3

196.16

244.09

u/ml

1.05

766

4940

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1561

8090

1.28

16.63

1.4

1.3

237.69

192.35

u/ml

0.49

1461

7515

Abnormal blood-pressure reading, without diagnosis

143

675

2.21

16.58

1.4

1.2

660.86

230.20

u/ml

0.70

123

623

GI-bleeding

792

5786

1.39

16.58

1.3

344.51

260.22

u/ml

0.70

735

5324

Tobacco use

205

1106

1.95

16.56

1.3

372.71

220.74

u/ml

1.64

187

1021

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

250

4258

0.58

16.50

1.3

367.87

237.99

u/ml

0.61

226

3918

Hypokalaemia

332

2046

1.67

16.42

1.4

1.3

280.77

215.13

u/ml

0.29

312

1888

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

774

5659

1.40

16.41

1.3

234.52

236.54

u/ml

0.03

727

5232

Gastric ulcer

415

2689

1.57

16.38

1.3

293.25

257.87

u/ml

0.16

389

2462

Other condition

478

3208

1.53

16.35

1.5

1.3

266.34

224.72

u/ml

0.38

447

2978

Disorders of oesophagus in diseases classified elsewhere

271

3.02

16.34

1.6

1.2

193.91

283.98

u/ml

0.37

244

Biological medication for rheuma

607

4271

1.46

16.32

1.4

1.3

154.90

221.76

u/ml

1.56

567

3968

Personality disorders

1063

8176

1.33

16.04

1.3

282.26

218.04

u/ml

0.29

963

7581

Malignant neoplasm of breast, HER2-negative

1070

10185

0.76

16.02

1.3

169.59

188.04

u/ml

0.39

968

9414

False labour

1473

7367

1.28

16.01

1.3

166.70

203.73

u/ml

0.65

1363

6855

Abnormal weight loss

268

1578

1.76

15.91

1.5

1.3

552.73

223.60

u/ml

0.73

252

1457

Diseases of tongue

204

1110

1.91

15.85

1.5

1.3

234.28

212.97

u/ml

0.14

189

1016

Purpura and other haemorrhagic conditions

418

2744

1.57

15.84

1.4

1.3

339.63

218.71

u/ml

1.42

372

2527

Disorders of adult personality and behaviour

1125

8733

1.31

15.83

1.3

278.15

216.47

u/ml

0.29

1024

8098

Other congenital malformations of skin

186

990

2.00

15.83

1.5

1.3

146.54

221.98

u/ml

1.18

169

920

Streptococcal septicaemia

237

1348

1.82

15.81

1.4

1.3

197.89

235.30

u/ml

0.48

216

1250

Vulvovaginal ulceration/inflammation in other diseases

273

1628

1.76

15.81

1.4

1.3

201.82

191.22

u/ml

0.07

252

1507

Other disorders of bladder

322

1988

1.66

15.80

1.3

222.98

250.55

u/ml

0.19

296

1815

Chondropathies

557

3880

1.47

15.77

1.4

1.3

382.75

218.11

u/ml

0.46

530

3602

Reactive arthropathies

290

1749

1.71

15.69

1.4

1.2

232.74

234.88

u/ml

0.01

272

1616

Hyperkinetic disorders

513

3486

1.50

15.68

1.4

1.3

280.69

297.35

u/ml

0.11

473

3250

Problems related to lifestyle

380

2451

1.60

15.67

1.3

1.2

349.86

196.79

u/ml

2.04

350

2276

Thyroiditis, ILD-related definition

437

2911

1.55

15.61

1.4

1.3

118.52

191.79

u/ml

2.91

402

2684

Superficial injury of ankle and foot

469

3171

1.53

15.60

1.4

1.3

200.59

233.18

u/ml

0.46

448

2935

Hyperparathyroidism

469

3120

1.52

15.57

1.3

190.48

208.30

u/ml

0.18

442

2858

Hypopituitarism

266

1578

1.76

15.52

1.5

1.3

275.85

260.50

u/ml

0.05

248

1466

SLE (Finngen)

148

732

2.15

15.47

1.2

135.84

160.16

u/ml

0.27

134

668

Appendectomy

2442

19843

1.20

15.45

1.3

193.42

237.56

u/ml

1.58

2264

18413

Female infertility

1314

6390

1.29

15.43

1.3

147.94

195.22

u/ml

1.86

1222

5923

Renal tubulo-interstitial diseases

2955

19366

1.18

15.43

1.4

1.3

290.34

233.93

u/ml

1.48

2726

17890

Acute nasopharyngitis (common cold)

394

2551

1.58

15.42

1.4

1.3

486.64

264.08

u/ml

1.16

368

2386

Other obstetric conditions, not elsewhere classified

1583

8296

1.26

15.42

1.4

1.3

236.31

189.88

u/ml

0.52

1479

7709

Psoriatic and enteropathic arthropathies

394

2572

1.58

15.35

1.3

199.35

214.36

u/ml

0.13

367

2389

Nonalcoholic fatty liver disease

329

2067

1.65

15.30

1.4

1.3

234.54

205.03

u/ml

0.37

314

1912

Nontoxic multinodular goitre

575

4048

1.45

15.23

1.4

1.3

118.76

199.27

u/ml

3.50

523

3693

Drug-induced cataract

105

457

2.49

15.23

1.6

1.2

284.16

210.88

u/ml

0.30

420

Benign neoplasm: Stomach

292

1781

1.69

15.19

1.6

1.3

144.04

203.99

u/ml

1.57

274

1627

Congenital malformations of the musculoskeletal system, not elsewhere classified

375

2.72

15.19

1.4

1.3

193.33

253.76

u/ml

0.26

348

Convulsions, not elsewhere classified

749

5439

1.38

15.19

1.4

1.2

329.50

268.72

u/ml

0.61

679

5058

Crohn's disease NAS

255

1505

1.77

15.19

1.4

1.3

164.95

208.35

u/ml

0.60

237

1403

Early lumbar disc prolapse, operated

392

2570

1.57

15.07

1.3

211.51

294.48

u/ml

0.94

372

2394

Benign neoplasm: Stomach

292

1785

1.69

15.07

1.6

1.3

144.04

229.19

u/ml

2.64

274

1638

Dementia

433

4442

0.67

15.02

1.3

234.48

252.83

u/ml

0.22

386

4026

Diseases of appendix

2738

21287

1.18

14.99

1.3

247.91

240.47

u/ml

0.09

2551

19743

Fracture of rib(s), sternum and thoracic spine

771

5710

1.37

14.95

1.3

302.25

271.02

u/ml

0.28

715

5273

Colonic or urogenital fistula

841

6318

1.36

14.94

1.3

153.18

242.92

u/ml

4.12

783

5826

Scoliosis

310

1929

1.66

14.93

1.3

193.04

203.66

u/ml

0.07

283

1771

Acne

455

3087

1.52

14.91

1.3

286.94

256.86

u/ml

0.22

427

2858

Pneumothorax

199

1094

1.88

14.91

1.5

1.3

278.81

230.38

u/ml

0.36

184

1002

Superficial injury of hip and thigh

403

2655

1.55

14.90

1.3

199.87

215.03

u/ml

0.23

374

2437

Iridocyclitis

716

5254

1.39

14.87

1.4

1.3

268.24

196.63

u/ml

0.69

666

4856

Pneumonia derived septicemia

117

535

2.31

14.84

1.6

1.2

150.26

243.51

u/ml

0.90

107

490

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

911

6931

1.34

14.79

1.4

1.3

223.65

254.82

u/ml

0.50

853

6420

Spontaneous rupture of synovium and tendon

234

1353

1.79

14.78

1.5

1.2

174.00

202.76

u/ml

0.24

216

1234

TMD muscular pain linked with fibromyalgia

219

3.32

14.74

1.7

1.2

108.04

227.67

u/ml

0.56

204

Postprocedural disorders of nervous system

320

2022

1.65

14.69

1.3

216.52

187.71

u/ml

0.15

295

1890

Crohn's disease of small intestine

271

1641

1.72

14.69

1.3

152.14

214.87

u/ml

1.00

257

1521

Appendicitis, broad definition

2717

21222

1.18

14.67

1.3

247.65

240.82

u/ml

0.09

2532

19685

Acute appendicitis, no complications

2078

17336

1.21

14.60

1.3

226.47

239.41

u/ml

0.23

1931

16099

Right bundle-branch block

103

448

2.40

14.59

1.6

1.3

443.12

248.99

u/ml

0.43

412

Inflammatory diseases of prostate (prostatitis)

309

1925

1.64

14.58

1.3

158.64

339.65

u/ml

6.50

283

1779

Endometriosis ASRM stages 1,2

739

5484

1.38

14.56

1.4

1.3

127.68

180.54

u/ml

1.14

675

5085

Schizophrenia

251

4115

0.60

14.44

1.2

1.3

798.11

239.30

u/ml

0.67

211

3841

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

197

3.29

14.42

1.7

1.2

2467.79

249.21

u/ml

0.67

178

IBD patients in KELA-register

826

6233

1.35

14.33

1.3

229.64

232.40

u/ml

0.02

768

5777

Mature T/NK-cell lymphomas, hilmo

198

3.27

14.30

1.7

1.2

2467.79

222.63

u/ml

0.68

179

Sequelae of other external causes

184

1004

1.91

14.30

1.5

1.3

325.83

214.17

u/ml

0.94

172

927

Coronary atherosclerosis

1825

9679

1.23

14.28

1.3

227.17

265.97

u/ml

0.86

1667

8930

Injuries to the head

4102

23484

1.15

14.26

1.3

256.07

248.81

u/ml

0.13

3792

21752

Other noninflammatory disorders of vulva and perineum

339

2183

1.60

14.17

1.3

463.35

208.68

u/ml

0.41

313

2008

Impetigo

205

1165

1.86

14.17

1.7

1.3

1827.53

234.44

u/ml

3.96

197

1083

Other disorders starting during childhood or adolecense, excluding more controls

244

1403

1.76

14.09

1.5

1.3

378.37

291.05

u/ml

0.37

221

1291

Perforation of tympanic membrane

325

2074

1.62

14.09

1.5

1.3

304.14

209.73

u/ml

0.62

301

1906

Hordeolum and other deep inflammation of eyelid

206

1174

1.83

13.94

1.4

1.3

255.89

225.08

u/ml

0.14

184

1080

Any dementia

358

3828

0.65

13.86

1.3

249.18

255.97

u/ml

0.06

317

3473

Paralytic ileus and intestinal obstruction

628

4555

1.40

13.84

1.4

1.3

218.32

243.44

u/ml

0.22

583

4185

Scabies

178

974

1.92

13.84

1.6

1.3

368.52

244.20

u/ml

0.37

162

909

Correction of physiology of bite - very demanding therapy visit

138

697

2.12

13.84

1.4

1.3

91.66

182.56

u/ml

1.81

130

648

Other otitis externa (chronic)

228

1340

1.77

13.81

1.5

1.3

260.09

221.91

u/ml

0.20

211

1245

Panniculitis affecting regions of neck and back

139

699

2.09

13.80

1.5

1.3

164.21

174.98

u/ml

0.12

131

648

Other neurological diseases

2103

14190

1.20

13.77

1.3

203.57

246.33

u/ml

1.19

1908

13117

Procreative management

1263

8514

1.27

13.76

1.4

1.3

199.65

260.26

u/ml

1.70

1165

7895

Protozoal diseases

105

477

2.35

13.71

2.0

1.2

183.31

255.37

u/ml

0.48

433

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

5.88

13.69

1.4

1.3

77.10

178.79

u/ml

1.90

Disorders of continuity of bone

332

2146

1.60

13.69

1.4

1.3

165.51

203.78

u/ml

0.71

301

1986

Other specified/unspecified soft tissue disorders

153

796

2.00

13.67

1.3

1.2

126.68

199.95

u/ml

1.08

138

727

Car occupant injured in other and unspecified transport accidents

677

4998

1.38

13.66

1.4

1.3

194.17

227.70

u/ml

0.67

634

4633

Benign neoplasm: Transverse colon

265

1621

1.68

13.64

1.4

1.3

182.46

230.72

u/ml

0.55

244

1487

Postmenopausal atrophic vaginitis

809

3649

1.36

13.63

1.3

159.47

191.48

u/ml

0.59

739

3366

Other superficial mycoses

410

2.47

13.59

1.4

1.3

173.11

170.60

u/ml

0.02

375

Other noninfective disorders of lymphatic vessels and lymph nodes

135

678

2.10

13.56

1.5

1.3

202.28

212.27

u/ml

0.07

125

620

Other benign neoplasms of skin

1082

8520

1.29

13.51

1.3

204.11

220.14

u/ml

0.23

1000

7818

Ulcer of oesophagus

178

975

1.88

13.50

1.4

1.3

259.83

258.25

u/ml

0.01

170

893

Adjustment and management of implanted device

411

2775

1.51

13.49

1.3

181.85

279.03

u/ml

3.11

382

2539

Seropositive rheumatoid arthritis, wide

795

6015

1.34

13.49

1.3

153.27

214.51

u/ml

2.57

736

5503

Blepharochalasis

747

5601

1.35

13.44

1.3

131.30

219.51

u/ml

5.22

670

5090

Explicit bacterial Sepsis

282

1757

1.65

13.41

1.5

1.3

216.42

238.32

u/ml

0.25

255

1630

Ankylosing spondylitis

284

1775

1.65

13.41

1.4

1.3

227.31

245.45

u/ml

0.07

270

1643

Other and unspecified epidermal thickening

107

495

2.30

13.37

1.4

1.2

249.59

248.74

u/ml

0.00

450

Oesophagitis

161

859

1.95

13.36

1.6

1.3

336.73

224.56

u/ml

0.62

151

790

Intestinal malabsorption

172

942

1.92

13.34

1.5

1.3

361.96

209.79

u/ml

0.39

157

872

Other and unspecified visual disturbances

303

1929

1.62

13.33

1.4

1.3

279.84

191.13

u/ml

0.44

278

1776

Degenerative diseases of the nervous system

284

3374

0.63

13.31

1.2

1.3

302.78

236.12

u/ml

0.82

256

3054

Glomerular diseases

520

3691

1.44

13.25

1.3

366.07

255.70

u/ml

0.48

477

3411

Acute appendicitis

2553

20660

1.18

13.23

1.3

228.61

237.16

u/ml

0.15

2376

19176

Varicose veins

1921

12124

1.21

13.20

1.3

190.80

228.87

u/ml

0.87

1765

11208

Other disorders of conjunctiva

377

2518

1.53

13.20

1.4

1.3

227.66

189.51

u/ml

0.33

350

2302

Follicular cysts of skin and subcutaneous tissue

554

3979

1.42

13.20

1.3

218.15

228.12

u/ml

0.13

509

3689

Any event in hilmo or specialist outpatient

5.32

13.19

1.1

997.35

116.22

u/ml

0.59

Acute gastritis

217

1271

1.76

13.15

1.4

1.3

277.04

238.87

u/ml

0.23

196

1167

Other CVD

418

2847

1.49

13.13

1.4

1.3

285.36

233.45

u/ml

0.27

386

2591

Female infertility, cervigal, vaginal, other or unspecified origin

1161

6168

1.28

13.06

1.3

139.19

193.38

u/ml

2.42

1081

5724

Other peripheral vascular diseases

266

1651

1.67

13.03

1.2

1.3

182.96

203.72

u/ml

0.21

247

1523

Benign neoplasm: Ascending colon

327

2125

1.58

13.03

1.4

1.3

207.58

207.03

u/ml

0.01

300

1938

Recurring oral aphthae

173

957

1.90

13.01

1.4

1.3

155.94

232.66

u/ml

0.75

159

879

Other specified/unspecified inflammatory spondylopathies

187

1058

1.84

12.98

1.3

207.15

197.90

u/ml

0.04

178

980

Other strabismus

813

6199

1.33

12.95

1.3

239.71

223.15

u/ml

0.18

753

5746

Hypertensive heart and/or renal disease

561

3112

1.42

12.94

1.3

238.10

253.70

u/ml

0.21

518

2832

Bruxism

100

460

2.37

12.91

1.6

1.3

158.60

200.61

u/ml

0.29

431

Olecranon bursitis

167

912

1.89

12.85

1.3

1.2

359.76

270.90

u/ml

0.49

155

829

Acute and subacute iridocyclitis

599

4380

1.40

12.82

1.4

1.3

251.69

193.94

u/ml

0.45

562

4053

Oligomenorrhoea

165

906

1.92

12.79

1.3

1.2

748.01

229.64

u/ml

0.41

153

835

Hypertensive Heart Disease

489

2804

1.45

12.77

1.3

223.43

254.00

u/ml

0.47

450

2549

Convalescence

194

1116

1.81

12.73

1.5

1.3

249.55

193.40

u/ml

0.28

177

1031

Fracture of foot, except ankle

820

6291

1.33

12.70

1.4

1.3

197.64

217.00

u/ml

0.39

775

5814

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

772

5872

1.34

12.67

1.3

143.43

212.13

u/ml

3.40

714

5369

Persistent mood disorders

630

4655

1.38

12.62

1.3

271.87

199.82

u/ml

0.85

571

4324

Dementia, including avohilmo

495

4791

0.71

12.60

1.3

245.51

249.53

u/ml

0.04

440

4351

AV-block

365

2209

1.52

12.57

1.2

1.3

228.23

304.85

u/ml

1.04

330

2016

Inflammatory bowel disease, strict (require KELA)

826

6354

1.32

12.56

1.3

229.64

231.40

u/ml

0.01

768

5888

Other erythematous conditions

124

621

2.10

12.55

1.3

1.2

251.39

225.90

u/ml

0.09

112

568

Fall on same level involving ice and snow

1841

15463

1.20

12.43

1.4

1.3

215.18

250.07

u/ml

0.83

1714

14278

Spinal instabilities

110

529

2.20

12.43

1.2

267.27

188.04

u/ml

0.30

101

488

Tumor necrosis factor alpha inhibitors

538

3895

1.42

12.43

1.3

130.90

220.35

u/ml

2.90

500

3618

Hypotension

338

2230

1.54

12.43

1.4

1.3

318.46

249.26

u/ml

0.30

310

2022

Other/unspecified seropositive rheumatoid arthritis

778

5941

1.33

12.41

1.3

147.92

212.72

u/ml

3.03

719

5435

Pericarditis

112

541

2.16

12.39

1.6

1.2

521.89

269.48

u/ml

0.63

107

501

Complications of internal orthopaedic prosthetic devices, implants and grafts

540

3903

1.41

12.32

1.4

1.3

211.66

236.85

u/ml

0.37

493

3542

Polyarthritis, unspecified

126

638

2.07

12.32

1.3

1.2

165.53

221.25

u/ml

0.50

119

580

Organic, including symptomatic, mental disorders

665

6402

0.74

12.27

1.3

237.73

246.86

u/ml

0.13

595

5845

Other maternal disorders predominantly related to pregnancy

2442

13168

1.18

12.25

1.3

164.72

201.84

u/ml

1.30

2242

12210

Benign neoplasm: Transverse colon

265

1667

1.64

12.24

1.4

1.3

182.46

241.67

u/ml

0.73

244

1543

Specific personality disorders

904

7065

1.30

12.24

1.3

311.90

208.53

u/ml

0.43

815

6555

Disorders of tooth development and eruption

227

1343

1.72

12.22

1.6

1.3

154.18

295.52

u/ml

2.31

213

1248

Stenosis and insufficiency of lacrimal passages

278

1770

1.62

12.22

1.4

1.3

167.58

188.56

u/ml

0.26

258

1617

Other diseases of stomach and duodenum

178

1008

1.82

12.21

1.5

1.2

492.36

210.21

u/ml

0.52

169

922

Nontoxic goitre/thyroid nodule

876

6813

1.31

12.20

1.3

112.06

189.35

u/ml

6.05

797

6230

Acute lymphadenitis

237

1458

1.69

12.18

1.6

1.3

404.58

222.57

u/ml

1.10

216

1340

Inflammatory diseases of the central nervous system

282

1806

1.61

12.16

1.4

1.3

241.47

215.76

u/ml

0.17

266

1666

Anterior Iridocyclitis

630

4684

1.37

12.15

1.4

1.3

265.47

208.12

u/ml

0.45

588

4336

Injuries to the shoulder and upper arm

2715

19719

1.16

12.14

1.3

253.59

262.15

u/ml

0.13

2521

18234

Deep endometriosis

363

2461

1.52

12.10

1.4

1.3

176.07

163.14

u/ml

0.09

336

2272

Alzheimer disease, including avohilmo

285

3174

0.64

12.03

1.2

1.3

271.88

247.24

u/ml

0.24

247

2867

Special screening examination for other diseases and disorders

247

1531

1.65

12.03

1.4

1.2

261.22

230.17

u/ml

0.27

228

1385

Other peripheral vertigo

270

1715

1.62

12.02

1.3

95.62

201.38

u/ml

5.36

252

1571

Injuries to the abdomen, lower back, lumbar spine and pelvis

1141

9105

1.26

12.02

1.4

1.3

318.51

244.78

u/ml

0.37

1052

8400

Fitting and adjustment of other devices

815

5839

1.31

11.96

1.3

183.10

244.07

u/ml

2.03

756

5326

Monoamine oxidase A inhibitors

356

2404

1.52

11.89

1.3

186.21

233.78

u/ml

0.64

320

2229

Open wound of wrist and hand

1424

11612

1.23

11.88

1.3

335.75

268.18

u/ml

0.74

1319

10773

Sacroiliitis, not elsewhere classified

189

1103

1.79

11.84

1.3

211.07

206.93

u/ml

0.03

184

1023

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

677

7238

0.75

11.84

1.2

1.3

190.35

192.78

u/ml

0.03

614

6701

Other and unspecified disorders of skin and subcutaneous tissue

206

1229

1.74

11.83

1.4

1.2

239.30

211.28

u/ml

0.18

177

1130

Other deformities of toe(s)

118

593

2.08

11.80

1.2

148.55

204.74

u/ml

0.41

107

538

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

290

1881

1.59

11.80

1.5

1.3

344.18

216.81

u/ml

0.67

270

1731

Secondary hypertension

231

1403

1.67

11.79

1.2

1.3

222.11

292.37

u/ml

0.69

217

1294

Systemic lupus erythematosus

148

807

1.94

11.78

1.3

1.2

135.84

183.49

u/ml

0.50

134

737

Giant cell arteritis

113

559

2.11

11.75

1.3

1.2

162.25

209.72

u/ml

0.38

104

505

Benign neoplasm: Ascending colon

327

2177

1.54

11.71

1.4

1.3

207.58

215.89

u/ml

0.09

300

2010

Benign neoplasm of mouth and pharynx

324

2155

1.54

11.71

1.4

1.3

233.79

212.44

u/ml

0.16

303

1985

Superficial injury of wrist and hand

705

5363

1.34

11.71

1.4

1.3

219.16

238.74

u/ml

0.19

645

4979

Pediculosis, acariasis and other infestations

208

1250

1.73

11.69

1.6

1.3

331.55

249.22

u/ml

0.27

190

1164

Reactive arthropathies, FINNGEN

242

1509

1.66

11.69

1.4

1.3

226.55

226.21

u/ml

0.00

227

1395

Other coagulation defects

256

1622

1.63

11.64

1.4

1.3

115.68

213.70

u/ml

2.93

241

1499

Erosion of teeth, including avohilmo

757

5621

1.33

11.63

1.4

1.3

209.35

223.10

u/ml

0.18

711

5215

Cerebrovascular diseases (FINNGEN)

1008

5707

1.28

11.62

1.3

252.55

240.18

u/ml

0.12

940

5314

Adalimumab

336

2263

1.53

11.58

1.3

103.49

222.03

u/ml

6.35

317

2106

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

203

1212

1.72

11.53

1.4

1.3

135.55

246.86

u/ml

3.05

188

1108

Haemorrhage in early pregnancy

1141

9012

1.26

11.49

1.3

148.86

192.74

u/ml

1.32

1056

8357

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

288

1877

1.58

11.49

1.4

1.3

198.81

241.95

u/ml

0.48

267

1742

Ventral hernia

647

4870

1.35

11.45

1.3

273.43

231.29

u/ml

0.27

608

4472

Other bullous disorders

103

500

2.18

11.44

1.6

1.3

696.76

244.62

u/ml

1.79

454

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

345

2333

1.51

11.44

1.5

1.3

773.70

236.38

u/ml

0.98

297

2152

Speech and linguistic disorders, excluding more controls

334

2119

1.53

11.40

1.4

1.3

457.77

291.07

u/ml

0.44

305

1969

Other benign neoplasms of skin

1082

8535

1.26

11.36

1.3

204.11

217.18

u/ml

0.18

1000

7902

Barrett oesophagus

131

691

1.97

11.34

1.4

1.3

377.48

242.18

u/ml

0.51

116

636

Left bundle-branch block

179

1037

1.77

11.33

1.3

1.2

287.13

247.57

u/ml

0.13

166

951

Unspecified kidney failure

210

1269

1.69

11.31

1.3

342.52

246.36

u/ml

0.30

194

1165

Familial hypercholesterolemia

363

2484

1.49

11.26

1.2

1.3

193.44

276.32

u/ml

1.45

338

2266

Short Achilles tendon (acquired)

106

523

2.14

11.25

1.5

1.2

141.96

208.65

u/ml

0.54

479

Benign neoplasm: Rectum

439

3118

1.44

11.21

1.3

151.69

223.82

u/ml

2.83

396

2849

Other and unspecified erythematous conditions

111

558

2.10

11.19

1.3

1.2

262.30

234.27

u/ml

0.09

100

509

Atrophic disorders of skin

446

3184

1.43

11.16

1.4

1.3

176.46

191.51

u/ml

0.24

409

2937

Heterophoria

309

2064

1.55

11.13

1.4

1.3

301.60

211.68

u/ml

0.59

285

1905

Pyogenic arthritis

181

1059

1.76

11.08

1.2

358.49

213.21

u/ml

0.85

168

966

Anosmia

350

2.37

11.00

1.5

1.3

351.49

192.85

u/ml

0.54

319

Dissociative [conversion] disorders

166

958

1.82

10.95

1.4

1.3

163.73

219.66

u/ml

0.56

154

898

Coxarthrosis, primary

1465

10567

1.21

10.90

1.3

301.41

239.31

u/ml

0.66

1330

9735

Glomerular disorders in diseases classified elsewhere

318

2139

1.52

10.89

1.2

1.3

429.02

234.64

u/ml

0.53

284

1967

SLE, ICD10

142

785

1.91

10.87

1.3

1.2

142.03

184.70

u/ml

0.41

128

717

SLE, strict definition

142

785

1.91

10.87

1.3

1.2

142.03

184.70

u/ml

0.41

128

717

Cytomegalovirus infection, IBD co-morbidity

411

2.29

10.87

1.7

1.3

344.49

249.11

u/ml

0.18

379

Other encephalitis

103

510

2.14

10.87

1.5

1.3

125.63

227.15

u/ml

1.16

465

Other pleural conditions

220

1360

1.65

10.86

1.3

204.12

234.93

u/ml

0.24

211

1248

Contraceptive management

1642

9692

1.21

10.85

1.3

175.09

252.52

u/ml

4.48

1548

9005

Effects of foreign body entering through natural orifice

757

5872

1.31

10.85

1.3

234.92

278.51

u/ml

0.58

709

5456

Secondary and unspecified malignant neoplasm of lymph nodes

227

1421

1.64

10.77

1.6

1.3

266.27

230.85

u/ml

0.14

196

1305

Alzheimer disease

228

2711

0.63

10.77

1.2

289.21

242.26

u/ml

0.44

202

2446

Calcific tendinitis of shoulder

190

1140

1.72

10.72

1.3

1.2

124.83

178.52

u/ml

1.53

173

1046

Encephalitis

110

561

2.07

10.70

1.4

1.3

122.19

235.89

u/ml

1.54

100

515

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2184

15361

1.17

10.66

1.3

201.11

202.62

u/ml

0.02

2027

14243

Hyperplasia of prostate

808

3566

1.31

10.66

1.4

1.3

263.10

340.68

u/ml

1.27

739

3322

Erosion of teeth

397

2.33

10.66

1.8

1.3

195.72

265.84

u/ml

0.28

363

Other disorders of kidney and ureter

339

2322

1.49

10.61

1.3

209.02

211.62

u/ml

0.02

316

2116

conjunctival haemorrhage

197

1196

1.70

10.58

1.4

1.2

178.88

193.00

u/ml

0.10

187

1099

Abnormal serum enzyme levels

685

5185

1.32

10.57

1.3

324.68

300.80

u/ml

0.11

639

4792

Other and unspecified injuries of ankle and foot

169

992

1.78

10.50

1.3

173.27

218.27

u/ml

0.66

164

918

Any dementia, excluding more controls

348

3484

0.69

10.50

1.3

247.01

235.87

u/ml

0.11

311

3166

Corneal ulcer

575

4317

1.36

10.49

1.4

1.3

465.86

206.26

u/ml

0.82

530

3994

Chronic suppurative otitis media, including avohilmo

263

1718

1.58

10.45

1.5

1.3

433.92

236.33

u/ml

0.86

247

1587

Benign neoplasm: Rectum

439

3158

1.42

10.45

1.3

151.69

234.94

u/ml

3.57

396

2917

Tuberculosis

144

801

1.84

10.45

1.5

1.2

227.77

236.77

u/ml

0.05

131

729

Other (seronegative) rheumatoid arthritis, wide

537

3991

1.37

10.45

1.3

152.20

198.31

u/ml

1.62

498

3662

Postprocedural endocrine and metabolic disorders, not elsewhere classified

413

2947

1.44

10.44

1.5

1.3

164.42

189.14

u/ml

0.39

388

2748

Nephropathy related operations

343

2365

1.48

10.41

1.3

272.64

227.50

u/ml

0.42

319

2174

Congenital malformations and deformations of the musculoskeletal system

380

2667

1.46

10.40

1.5

1.3

324.72

249.65

u/ml

0.38

348

2487

Chondrocostal junction syndrome [Tietze]

137

759

1.89

10.37

1.5

1.2

184.61

201.98

u/ml

0.13

131

695

Strabismus

910

7258

1.27

10.30

1.3

227.91

223.36

u/ml

0.05

842

6724

Dialysis, with operation codes

350

2428

1.47

10.28

1.3

338.15

230.45

u/ml

0.59

326

2237

Fall on and from stairs and steps

744

5800

1.30

10.28

1.3

233.90

218.99

u/ml

0.22

682

5355

Other noninflammatory disorders of vagina

266

1749

1.57

10.27

1.2

1.3

124.66

216.98

u/ml

2.90

242

1602

Cramp and spasm

165

968

1.78

10.25

1.4

1.3

149.08

215.40

u/ml

1.14

153

892

Other disorders of binocular vision

300

2.50

10.22

1.5

1.3

119.77

171.09

u/ml

0.75

278

Acne vulgaris

341

2365

1.49

10.20

1.3

266.18

250.47

u/ml

0.13

318

2185

Cytomegaloviral disease

442

2.19

10.19

1.7

1.3

333.41

249.72

u/ml

0.17

408

Dental caries 2 and operation codes, only avohilmo

2839

15484

1.15

10.18

1.3

242.70

241.11

u/ml

0.02

2611

14355

Recurrent dislocation and subluxation of joint

252

1641

1.58

10.17

1.4

1.3

183.48

253.23

u/ml

0.84

231

1527

Faecal incontinence

232

1480

1.61

10.15

1.4

1.2

139.92

207.35

u/ml

1.55

217

1347

Arthropathies in other diseases classified elsewhere

116

612

1.98

10.14

1.4

1.2

285.49

243.13

u/ml

0.12

105

553

Cerebral palsy and other paralytic syndromes

350

2436

1.47

10.13

1.4

1.3

198.47

223.85

u/ml

0.31

323

2256

Benign neoplasm of mouth and pharynx

324

2223

1.49

10.13

1.4

1.3

233.79

233.33

u/ml

0.00

303

2055

Phlebitis and thrombophlebitis (not including DVT)

634

4849

1.33

10.12

1.4

1.3

182.59

224.40

u/ml

0.96

584

4483

Erythema intertrigo

324

2.37

10.10

1.3

1.2

202.59

180.74

u/ml

0.14

291

Other disorders of pigmentation

147

838

1.83

10.08

1.4

1.2

198.49

221.66

u/ml

0.14

138

764

Additional codes for the location of defect, injury or illness

188

1146

1.70

10.08

1.4

1.3

270.85

219.11

u/ml

0.24

176

1065

Malignant neoplasm of digestive organs

486

6453

0.73

10.07

1.2

1.3

201.72

247.10

u/ml

0.86

434

5889

Idiopathic gout

202

1249

1.66

10.05

1.4

1.3

382.59

255.55

u/ml

0.98

189

1143

Hyperimmunoglobulin E [IgE] syndrome

37.64

10.04

5.7

1.2

3870.38

70.91

u/ml

—

Haemorrhage, not elsewhere classified

461

2.11

10.02

1.3

1.2

130.41

262.52

u/ml

1.15

418

Benign neoplasm: Sigmoid colon

442

3207

1.40

10.01

1.3

307.96

230.64

u/ml

0.30

406

2929

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

577

4230

1.35

9.95

1.3

209.84

258.26

u/ml

0.91

552

3927

Postmenopausal bleeding

811

3487

1.30

9.93

1.3

176.92

194.45

u/ml

0.30

718

3219

Other acute skin changes due to ultraviolet radiation

115

610

1.97

9.92

1.4

1.2

570.05

172.10

u/ml

1.22

106

561

Pneumococcal septicemia

112

590

1.99

9.90

1.6

1.3

155.47

254.26

u/ml

1.03

102

536

Other/unspecified soft tissue disorders related to use, overuse and pressure

109

570

2.01

9.86

1.4

1.3

124.82

205.46

u/ml

0.77

102

519

Chalazion

355

2492

1.46

9.84

1.3

464.43

219.54

u/ml

0.77

334

2289

Contusion of other and unspecified parts of foot

195

1210

1.68

9.81

1.4

1.3

249.67

232.67

u/ml

0.12

185

1119

Psoriasis (vulgaris), strict definition

115

615

1.96

9.75

1.5

1.3

441.63

232.17

u/ml

0.93

106

572

Excessive vomiting in pregnancy

350

2464

1.47

9.75

1.4

1.3

103.05

198.20

u/ml

1.59

333

2293

Endometriosis of ovary

606

4625

1.33

9.74

1.3

139.01

190.80

u/ml

1.31

560

4271

Dysplasia of cervi uteri

941

5857

1.26

9.74

1.2

1.3

213.04

198.63

u/ml

0.14

865

5445

Toxic effect of contact with venomous animals

147

849

1.81

9.71

1.3

263.48

241.84

u/ml

0.13

136

783

Glaucoma suspect

902

7242

1.26

9.70

1.3

178.52

231.30

u/ml

1.54

831

6620

Glucagon-like peptide-1 (GLP-1) analogues

1394

9592

1.21

9.69

1.3

368.17

231.51

u/ml

2.24

1277

8838

Synovial cyst of popliteal space [Baker]

192

1185

1.66

9.67

1.2

249.83

207.90

u/ml

0.26

182

1078

Alzheimer’s disease, wide definition

166

2286

0.60

9.58

1.2

301.37

240.90

u/ml

0.47

145

2059

Disturbances of smell and taste

140

800

1.82

9.55

1.3

1.2

266.40

203.86

u/ml

0.30

128

729

Infections with a predominantly sexual mode of transmission

1195

9905

1.22

9.52

1.3

279.43

208.50

u/ml

1.09

1091

9202

Other disorders of gingiva or/and edentulous alveolar ridge

153

897

1.77

9.47

1.3

145.69

224.99

u/ml

1.74

137

824

Hodgkin lymphoma, hilmo

104

544

2.01

9.44

1.4

1.3

315.39

244.32

u/ml

0.24

502

Superficial injury of shoulder and upper arm

341

2395

1.46

9.44

1.3

232.41

212.62

u/ml

0.18

324

2212

Medial epicondylitis

137

781

1.83

9.43

1.4

1.2

136.54

185.86

u/ml

0.61

129

716

Systemic sclerosis (FG)

455

2.12

9.42

1.4

1.2

79.59

216.38

u/ml

1.74

418

Scleritis and episcleritis

218

1403

1.61

9.40

1.4

1.3

138.50

182.07

u/ml

0.96

204

1291

Malignant neoplasm of breast, HER-positive

670

8431

0.77

9.40

1.2

1.3

192.06

176.57

u/ml

0.24

607

7763

Acute tubulo-interstitial nephritis

1936

14814

1.17

9.39

1.3

236.49

225.66

u/ml

0.17

1787

13646

Substance use, excluding alcohol

648

5028

1.31

9.38

1.4

1.3

338.33

246.26

u/ml

1.05

607

4682

Sequelae of injuries of upper limb

312

2163

1.48

9.32

1.4

1.3

160.72

211.86

u/ml

1.08

293

2007

Thyrotoxicosis, other and/or unspecified

625

4833

1.32

9.29

1.3

184.42

207.59

u/ml

0.39

586

4443

Benign neoplasm: Rectum, anus and anal canal

479

3564

1.37

9.28

1.3

150.26

241.86

u/ml

4.19

435

3259

Open wound of head

1496

12481

1.19

9.25

1.3

309.85

280.80

u/ml

0.39

1384

11540

Fracture at wrist and hand level

1067

8770

1.23

9.20

1.3

406.68

270.28

u/ml

1.04

986

8134

Misadventures to patients during surgical and medical care

405

2944

1.40

9.18

1.4

1.3

225.07

199.09

u/ml

0.27

377

2709

Polyp of the female genital tract

1105

5272

1.23

9.15

1.3

118.21

192.17

u/ml

6.08

1019

4868

Benign neoplasm: Sigmoid colon

442

3257

1.38

9.14

1.3

307.96

231.24

u/ml

0.30

406

3008

Other or unspecified ileus, impaction or obstruction

413

3005

1.39

9.14

1.4

1.3

165.69

267.43

u/ml

2.33

388

2763

Diseases of arteries, arterioles and capillaries

1683

10718

1.18

9.14

1.3

289.54

250.98

u/ml

0.68

1551

9870

Vitamin deficiency

151

892

1.75

9.13

1.4

1.3

226.55

191.66

u/ml

0.27

139

821

Vitamin deficiency, wide

151

892

1.75

9.13

1.4

1.3

226.55

191.66

u/ml

0.27

139

821

Leisure time condition

538

4087

1.34

9.12

1.4

1.3

305.69

231.08

u/ml

1.12

501

3780

Disorders of eyelid in diseases classified elsewhere

116

636

1.91

9.11

1.7

1.2

1512.89

195.28

u/ml

0.89

109

581

Other/unspecified rheumatoid arthritis

327

2295

1.45

9.06

1.3

145.83

196.01

u/ml

1.29

307

2107

Other disorders of nervous system

191

1202

1.64

9.00

1.4

1.3

278.15

204.58

u/ml

0.35

172

1108

Psychotic depression

200

1272

1.62

8.99

1.3

300.38

205.14

u/ml

0.39

177

1174

Embedded and impacted teeth

1069

7491

1.23

8.97

1.3

219.76

286.60

u/ml

1.00

1000

6884

Sleep disorders, other/unspecified

136

788

1.81

8.95

1.4

1.3

237.65

240.36

u/ml

0.01

129

730

Benign neoplasm: Caecum

240

1593

1.54

8.86

1.5

1.3

170.84

204.27

u/ml

0.56

218

1453

Benign neoplasm: Rectum, anus and anal canal

479

3591

1.35

8.85

1.3

150.26

233.10

u/ml

3.97

435

3313

Exclusions for E4_PCOS_CONSORTIUM

2886

16061

1.14

8.85

1.3

184.32

212.94

u/ml

0.79

2669

14866

509

2.02

8.85

1.3

1.2

183.61

201.15

u/ml

0.13

468

Herpesviral keratitis and keratoconjunctivitis

137

796

1.79

8.83

1.9

1.2

1741.52

179.77

u/ml

1.29

124

729

Postmenopausal osteoporosis with pathological fracture

138

801

1.77

8.83

1.6

1.2

217.35

166.52

u/ml

0.32

126

726

Emotionally unstable personality disorder

495

3744

1.35

8.81

1.3

381.72

206.98

u/ml

0.40

447

3485

Use of other anti-dementia drugs

173

2402

0.62

8.79

1.2

333.38

241.48

u/ml

0.84

156

2161

Use of memantine

173

2402

0.62

8.79

1.2

333.38

241.48

u/ml

0.84

156

2161

Cardiodefibrillation

775

6175

1.27

8.79

1.3

269.59

279.31

u/ml

0.09

722

5660

Other infective otitis externa

192

1219

1.63

8.77

1.4

1.3

547.21

201.04

u/ml

0.72

180

1131

Benign lipomatous neoplasm

836

6742

1.26

8.74

1.3

182.42

234.10

u/ml

1.57

775

6209

Unspecified urinary incontinence

254

1715

1.52

8.70

1.4

1.2

169.18

176.06

u/ml

0.09

230

1573

Disorders of mineral metabolism

226

1491

1.55

8.64

1.3

273.14

224.11

u/ml

0.15

209

1376

Medicines for HER+ breast cancer

735

8946

0.79

8.63

1.3

187.26

176.53

u/ml

0.17

670

8230

Monoarthritis, not elsewhere classified

136

793

1.78

8.63

1.3

292.54

227.96

u/ml

0.18

123

730

Phobic anxiety disorders

501

3803

1.34

8.61

1.3

152.45

237.47

u/ml

3.19

454

3534

DVT of lower extremities

472

3546

1.35

8.60

1.4

1.3

220.03

242.24

u/ml

0.22

432

3262

Event of undetermined intent

216

1416

1.57

8.60

1.5

1.3

232.05

228.48

u/ml

0.02

203

1304

Bicipital tendinitis

142

839

1.75

8.58

1.3

1.2

161.64

222.50

u/ml

0.47

132

768

Radial styloid tenosynovitis [de Quervain]

193

1234

1.61

8.57

1.2

1.3

187.91

207.70

u/ml

0.13

180

1136

Open wound of ankle and foot

309

2173

1.45

8.56

1.3

315.77

245.99

u/ml

0.71

288

2004

Thyrotoxicosis

785

6307

1.26

8.56

1.4

1.3

177.66

208.18

u/ml

0.57

733

5798

L04AC Interleukin inhibitors

184

1167

1.64

8.54

1.5

1.3

206.29

213.91

u/ml

0.04

171

1087

Tongue abnormality

180

1133

1.64

8.53

1.4

1.3

184.73

206.71

u/ml

0.19

169

1034

Systemic lupus erythematosus, unspecified

121

689

1.85

8.51

1.2

146.50

188.66

u/ml

0.36

111

632

Melanocytic naevi of trunk

371

2697

1.41

8.50

1.3

166.18

204.23

u/ml

0.35

352

2494

Other disorders starting during childhood or adolescence

248

1670

1.53

8.49

1.5

1.3

372.10

304.37

u/ml

0.27

225

1549

Other/unspecified cytomegaloviral diseases

351

2.22

8.48

1.8

1.3

390.92

262.90

u/ml

0.21

324

Cardiomyopathy

405

2978

1.38

8.47

1.4

1.3

209.95

300.64

u/ml

1.74

385

2747

Presence of cardiac and vascular implants and grafts

986

6112

1.23

8.47

1.2

1.3

198.58

290.79

u/ml

3.73

904

5638

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

248

1680

1.52

8.46

1.3

149.95

232.11

u/ml

1.26

230

1564

Hodgkin lymphoma

104

566

1.93

8.42

1.4

1.3

315.39

240.32

u/ml

0.26

526

Epiphora

378

2.15

8.41

1.2

219.69

226.62

u/ml

0.03

344

R07AX Other respiratory system products

+∞

8.40

5.1

1.4

94.40

196.24

u/ml

—

Sacrococcygeal disorders, not elsewhere classified

115

646

1.86

8.40

1.3

246.43

195.26

u/ml

0.23

108

600

Injuries to the hip and thigh

1206

9251

1.20

8.39

1.3

216.65

256.33

u/ml

0.99

1108

8504

Gingival hyperplasia

109

602

1.89

8.39

1.3

138.91

235.27

u/ml

1.88

559

Endometriosis ASRM stages 3,4

822

6662

1.25

8.36

1.3

160.51

188.72

u/ml

0.38

758

6131

Chronic suppurative otitis media

211

1384

1.57

8.32

1.5

1.3

477.13

252.87

u/ml

0.79

200

1272

Subacute thyroiditis

130

759

1.79

8.32

1.4

1.2

123.99

177.46

u/ml

0.59

125

691

Other ulcerative colitis

201

1309

1.59

8.27

1.4

1.3

224.13

213.02

u/ml

0.06

186

1219

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

998

8251

1.22

8.26

1.3

367.38

212.83

u/ml

0.83

916

7682

Congenital malformations of the circulatory system

494

3649

1.34

8.25

1.2

1.3

191.15

263.90

u/ml

1.52

463

3386

Myositis

393

2.10

8.25

1.3

1.2

141.29

232.89

u/ml

0.64

354

Temporal arteritis

504

1.96

8.23

1.3

1.2

159.56

222.68

u/ml

0.47

455

Perioral dermatitis

502

1.99

8.18

1.7

1.2

210.87

219.32

u/ml

0.03

462

Epilepsy

859

6977

1.24

8.16

1.4

1.3

165.22

268.79

u/ml

3.73

767

6432

Pyothorax

110

613

1.86

8.15

1.4

1.3

158.98

268.77

u/ml

1.30

101

568

Infective bursitis

429

2.04

8.15

1.3

1.2

161.10

208.42

u/ml

0.42

394

Calculus of kidney and ureter

756

6077

1.26

8.14

1.3

271.59

255.66

u/ml

0.13

708

5620

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

IgE [Units/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS